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RESUMO 
 
 Neste trabalho, foram investigadas a química de coordenação e bioatividade 
de complexos de cobre(II) com N-heterociclos contendo imidazol ou tetrazol em sua 
estrutura. A estrutura cristalina dos ligantes mostrou que a presença de ligações de 
hidrogênio entre os anéis imidazólicos ou tetrazólicos possui uma grande 
contribuição na determinação do seu empacotamento. Dados de difração de raios X 
mostraram que a geometria quadrada planar é adotada pelos complexos contendo 
ligantes bidentados ou monodentados, com fórmulas de coordenação [CuCl2(L)] e 
[CuCl2(X)2], L = impy, impm and impz e X = thim, respectivamente. Análises 
elementares e de espectrometria de massas concordaram com as estequiometrias 
propostas. Técnicas espectroscópicas mostraram que a mudança do número ou 
posição de átomos de nitrogênio em um anel pode resultar em mudanças 
significativas nas propriedades eletrônicas e vibracionais tanto dos ligantes isolados 
quanto dos complexos. Os ligantes impy, impm e impz não mostraram atividade 
sobre E. coli e S. aureus, enquanto seus respectivos complexos, [CuCl2(impy)], 
[CuCl2(impm)] e [CuCl2(impz)], foram ativos contra estas cepas (MIC = 17.8 
µmol·mL-1), mas sem distinção entre os complexos e a cepa testada, o que pode ser 
relacionado à carga dos complexos após a hidrólise dos cloretos. Experimentos 
biofísicos indicaram que o complexo trans [CuCl2(thim)2] interage covalentemente 
com o DNA, um possível alvo molecular dos complexos e também mostrou atividade 
antifúngica sobre Trichophyton mentagrophytes. 
 
 
  
 
 
 
 
ABSTRACT 
 
 The coordination chemistry and bioactivity profiles of copper(II) complexes 
with N-heterocycles containing imidazole and tetrazole in their structures have been 
investigated. The crystal structures of the ligands showed that hydrogen bonding 
between either the imidazole or the tetrazole rings has an important effect on 
determining their packing. Based on X-ray diffraction data, square planar geometry 
was proposed for the complexes containing bidentate or monodentate ligands with 
coordination formulas [CuCl2(L)] and [CuCl2(X)2], L = impy, impm and impz and X = 
thim, respectively. Elemental analysis and mass spectrometry results were in 
agreement with the proposed stoichiometries. Spectroscopic techniques showed that 
changing either the number or position of nitrogen atoms in a ring can result in 
significant changes in the electronic and vibrational properties of both the isolated 
ligands and the complexes. The imidazolic ligands impy, impm and impz showed no 
activity over E. coli and S. aureus, whereas their respective complexes, 
[CuCl2(impy)], [CuCl2(impm)] and [CuCl2(impz)], showed some activity towards these 
strains (MIC = 17.8 µmol·mL-1), but with no distinction between the complexes and 
the tested strain, which may be due to the charge of the complexes after hydrolysis. 
Biophysical experiments showed that the trans complex [CuCl2(thim)2] interacts 
covalently with DNA, a possible molecular target for this complex, and it also showed 
antifungal activity over the Trichophyton mentagrophytes strain. 
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Chapter 1  
 
 
Introduction 
 
 
1.1. Metals in Medicine 
 
Several transition metals are present in biological systems and some of them 
are essential for life. Medicinal inorganic chemistry is the field of knowledge that uses 
the fundamentals of inorganic chemistry for the therapy or diagnosis of diseases.[1] 
The development of new metal complexes for the treatment of diseases rose 
exponentially after the discovery of the bioactivity of cisplatin (see Figure 1.1. (a)), by 
Barnett Rosenberg. Rosenberg found that cisplatin is capable of inhibiting cell 
division in Escherichia coli (E. coli).[2,3] Cisplatin is currently used worldwide for the 
treatment of several cancers and it is estimated that half of all patients that undergo 
chemotherapy are treated with a platinum compound.[4] Patients diagnosed with 
testicular cancer and treated with cisplatin have above 90 % chance of long-term 
survival rates.[1,5,6]  
The main mechanism of action of cisplatin involves the hydrolysis of the 
chloride ions and subsequent covalent binding of the [Pt(NH3)2]
2+ moiety to either 
guanine or adenine residues of DNA (more specifically to the N-7 atom of either 
nucleotides), via interstrand or intrastrand cross-links. These adducts interfere in the 
normal cell division process, thus leading to apoptosis.[5,7–9] 
Besides platinum, the use of several other metals in different oxidation states, 
geometries and with different ligands has been explored and resulted in many 
complexes with promising bioactivity.[1,6,10,11]  
Gold(I) complexes, such as auranofin (Figure 1.1. (b)), have been used 
clinically used for the treatment of rheumatoid arthritis, though they were eventually 
15 
 
 
 
substituted by organic molecules due to side effects. The mechanisms of action of 
such gold complexes are still not completely elucidated.[1]  
 
Figure 1.1. Chemical structures of (a) anticancer cisplatin (b) anti-rheumatoid arthritis 
auranofin and (c) antibacterial silver sulfadiazine. 
  
Palladium(II) and gold(III) complexes are isoelectronic with the Pt(II) ion – d8 
electronic configuration – and have been investigated for the treatment of cancer, 
resulting in promising compounds, such as gold(III)-porphyrin[12] and gold(III)-
dithiocarbamates complexes.[13]  
Silver(I) compounds are widely reported as antibacterial agents. A clinical 
example of such a compound is silver sulfadiazine (Figure 1.1.(c)), used topically for 
the prevention of bacterial infection on burns. Silver ions have been reported to be 
bioactive via several mechanisms, including modification of mitochondrial structure[14] 
and interaction with biomolecules like DNA and enzymes involved in metabolism.[15] 
Beyond these metals that have no reported biological function in organisms, 
essential metals have also been explored for the development of metallodrugs. 
Important examples include copper-based complexes. They have been investigated 
based on the fact that endogenous metals may be less toxic for normal cells than to 
cancer cells and on the fact that copper itself has antimicrobial effects.[16–18] More 
about copper (bio)chemistry and the use of its complexes for medicinal purposes is 
discussed on the next item. 
 
1.2. Chemistry and biological aspects of copper  
 
Copper is among the thirty most abundant elements in the earth’s crust and it 
exists as two stable isotopes and nine radioactive isotopes. This element has played 
an important role in human history, as copper compounds have been used 
16 
 
 
 
extensively in a wide range of applications, including catalysis, agriculture as 
fungicides and as a pigment.[19,20] 
Copper possesses a rich coordination chemistry. The most common oxidation 
states are I and II, the latter being the most abundant. Copper(I), of electronic 
configuration [Ar] 3d10, acts as a soft Lewis acid, so it forms complexes preferably 
with soft bases, such as phosphines and thiols. Cu(I) is easily oxidized to Cu(II) or it 
can disproportionate to Cu(0) and Cu(II). The copper(II) ion has a [Ar] 3d9 electronic 
configuration and it has a borderline acid character, which makes nitrogen, oxygen 
and chloride donors good ligands for Cu(II).[20–23] 
As the other metal(II) ions from the first transition series, copper(II) forms 
complexes with a variety of coordination numbers, four, five and six being the most 
common (see Figure 1.2). However, the [Ar] 3d9 electronic configuration of Cu(II) is 
prone to the Jahn-Teller effect due to the degenerate eg state (dz2 and dx2-y2 orbitals) 
an octahedral field would impose, leading to a variety of distorted structures.[19,22,24] 
This versatility of Cu(II) in forming coordination compounds results in more 
coordination complexes of this metal than of any other metal from the periodic 
table.[20,24] 
 
Figure 1.2. Examples of geometries of the most common coordination numbers 
adopted by copper(II) complexes. Adapted from reference [23]. 
 
The rich coordination chemistry of copper is also observed in nature. The 
presence of copper in biological systems dates to around 2 billion years ago, which is 
the time of rising oxygen levels in the atmosphere. This resulted in the overall 
oxidation of Cu(I) to the soluble and bioavailable Cu(II) ions. Concomitantly, the 
oxidative atmosphere resulted in Fe(II) oxidation to Fe(III), which is more insoluble 
due to the formation of Fe(OH)3, which resulted in copper becoming more common in 
biological systems.[2,21,25] 
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Copper is an essential (trace) element in many organisms, as it is part of many 
enzymes.[23,26,27] The main ligands for copper in these cuproenzymes are the amino 
acid histidine, methionine and cysteine. The structural and redox versatility this metal 
possesses leads to a variety of enzymes with different functions, some of which are 
listed in Table 1.1. 
 
Table 1.1. A small list of copper proteins and their functions. Adapted from reference 
[27]. 
Copper protein/ enzyme Function 
Electron transfer proteins  
Azurin Electron transfer in respiration 
Plastocyanin Electron transfer in photosynthesis 
Cytochrome c oxidase Electron transfer in respiration 
  
Oxidoreductases  
Ascorbate oxidase Oxidation of ascorbate 
Ceruloplasmin Oxidation of Fe(II) to Fe(III) 
Cu, Zn-SOD Superoxide dismutation 
Laccase, Tyrosinase Oxidation of phenols 
Nitrite reductase Reduction of NO2
- to N2 
  
Other  
Hemocyanin Oxygen transport 
 
Type I copper proteins usually have a role in electron transfer reactions. The 
copper center is coordinated to two histidine residues and to one sulfur from a 
methionine, in a trigonal planar geometry, with varying axial ligand. These proteins 
show a strong absorption around 600 nm, due to a charge transfer from sulfur to 
copper, which usually leads to a blue color. Thus, these type I enzymes are usually 
called blue copper proteins. Plastocyanin (Figure 1.3 (a)), an enzyme involved in 
electron transfer reactions in photosynthesis, is an example of a type I copper 
enzyme. 
Type II copper centers in enzymes usually show a distorted square geometry, 
with the metal ion usually bound to nitrogen atoms from histidine residues, though 
oxygen donors are also observed. An example of enzyme from this class is Cu, Zn 
superoxide dismutase (see Figure 1.3 (b)). This enzyme was firstly reported in 1969 
by Fridovich and McCord[28], the copper center is responsible for the dismutation of 
potentially harmful superoxide radical ions that result from metabolism, whereas zinc 
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plays a structural role. In this enzyme, the metal ions are bridged by an imidazolate 
ion. 
Finally, type III copper containing enzymes show binuclear copper centers, 
with each metal bound by three nitrogens from histidine residues and coupled 
antiferromagnetically. These centers are found in some oxidases, such as tyrosinase, 
which participates in some steps on the conversion of L-tyrosine to melanin and in 
hemocyanin (see Figure 1.3 (c)). The latter is a protein responsible for oxygen 
transport in some invertebrate animals.[23,25,27] 
 
 
Figure 1.3. Active sites of copper(II)-containing proteins: (a) plastocyanin, (b) 
copper-zinc superoxide dismutase, (c) oxygenated form of hemocyanin. Adapted 
from references [27] and [29]. 
 
Ingested copper is mainly absorbed in the small intestine. Before entering the 
cells, the Cu(II) ions are reduced on their surfaces and transported across the cell 
membrane by the human copper transporter enzyme. Inside the cell, chaperones are 
responsible for copper trafficking, while glutathione and metallothioneins ensure that 
almost no free copper capable of redox cycling (and thus leading to cellular damage) 
is available. In the liver, copper is incorporated into ceruloplasmin, which contains six 
copper ions in its structure and acts as a ferroxidase. Excess copper is usually 
eliminated via biliary excretion.[17,23,30,31]  
In the work by Rae et al., the authors showed that the cellular mechanisms of 
preventing oxidative damage by copper redox cycling are so efficient that the 
concentration of free copper in yeast cells is less than 10-18 mol·L-1. By taking the cell 
volume into account, less than one free copper ion is present per cell.[32] 
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 Contrary to the low sensitivity of human tissues to copper, microorganisms are 
much more susceptible to the toxic effects of this metal.[16,17,33] One of the first reports 
of the use of copper for the water sterilization dates 2200 B.C., from an ancient 
Egyptian medicinal text.[34] 
 The mechanisms of copper toxicity to microorganisms may involve the Cu(I)/ 
Cu(II) redox cycling, which is greatly avoided in human cells, as mentioned before. It 
is suggested that elevated copper concentrations leads to cell membrane damage via 
generation of free radicals, thus leading to leakage of intracellular components and to 
cell death. Copper can also interact with DNA via covalent or noncovalent 
(intercalation, groove binding and electrostatic) modes, depending on the structure of 
the ligand.[35] Oxidative DNA strand breakage may result, especially in the presence 
of reducing agents, which results in the generation of more Cu(I) and, consequently, 
of reactive oxygen species via a Fenton mechanism.[16,17,33]  
However, non-Fenton chemistry has also been suggested as mechanisms of 
antibacterial activity of copper, and involves the Cu(I) ion. Copper in this oxidation 
state is absorbed by the cell. In anoxic conditions, the Cu(I) state is predominant and 
exhibits intense thiophilicity, which may disrupt key cytoplasmic iron-sulfur enzymes, 
resulting in disruption of bacterial metabolism.[21] 
Currently, copper salts are extensively employed in agriculture. The use of 
copper salts as fungicides became more common with the use of a mixture of copper 
sulphate, lime and water called “Bordeaux mixture”, which is used to this date.[16,20] 
Metallic copper is used for the production of antibacterial door handles, bed rails, 
toilet seats, especially useful to prevent bacterial proliferation in hospitals.[34] Copper 
oxide nanoparticles were recently reported to be active over yeast with generation of 
reactive oxygen species and lipid peroxidation mechanisms.[36] 
It is thus not surprising that other copper compounds, besides metallic copper 
and its simple salts, have also been investigated due to their antimicrobial activities. 
Copper(II) coordination complexes have been widely investigated not only for their 
antimicrobial properties[37–39], but also for their anticancer activities[18,23,40,41], for the 
treatment of Alzheimer’s disease, of diabetes, of inflammation processes.[39]  
Copper(II) complexes containing ligands such as 2,2’-bipyridine (bipy) or 1,10-
phenantroline (phen), shown in Figure 1.4, are widely reported as antibacterial, 
anticancer and antifungal compounds.[18,39] Copper complexes with substituted bipy 
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and phen and another anionic ligand (aminoacidates or acetylacetonate, for example) 
are examples of promising anticancer compounds of this metal and are patented 
under the name Casiopeínas. These compounds were also shown to be promising as 
anti-Tripanosoma cruzi agents.[42,43] 
As the copper(II) ion, the in vitro activity of the complexes is usually related to 
their DNA binding, followed by its oxidative cleavage. Copper–phen complexes were 
first reported as artificial nucleases in 1979. The aromatic character of the phen 
ligand allows the intercalation of the complex in DNA, so that the reactive species are 
generated in close proximity of the target.[44,45] 
 
 
Figure 1.4. Chemical structures of (a) 2,2’-bipyridine, (b) 1,10-phenantroline (phen) 
and Casiopeínas (c) Cas III-ia and (d) Cas III-Ea. 
 
Imidazole, benzimidazole and derivatives form promising antibacterial and 
antigunfal complexes with Cu(II). Thiosemicarbazones of imidazole and 
benzimidazole and their corresponding copper complexes were shown to be active 
against the yeast Saccharomyces cerevisiae and Gram-positive bacteria such as 
Staphylococcus aureus (S. aureus).[46] A copper complex of benzimidazole and L-
arginine showed activity against both Gram-positive and Gram-negative bacteria.[38] 
The combination of imidazole and moxifloxacin led to a copper(II) complex active 
over E. coli and S. aureus.[47] These are just some examples of complexes with 
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potential antimicrobial applications and new examples are constantly being published 
in the literature. 
The following section is dedicated to the discussion of the chemistry and 
biological and medicinal properties of some N-heterocyclic molecules studied in this 
work. 
 
1.3. Chemistry and biological properties of N-heterocycles  
 
 N-heterocyclic molecules have long been explored as ligands in coordination 
chemistry. The borderline base character of nitrogen allows it to coordinate a several 
metals, thus leading to a variety of molecular architectures. Nitrogen is one of the 
most frequent donor atom for copper(II) complexes.[22] 
 Among the five-membered nitrogen-containing heterocycles, imidazole and 
tetrazole are vastly reported for the formation of compounds with promising 
properties. Imidazole is a five-membered aromatic heterocycle containing, in addition 
to a tertiary nitrogen, an imino group.[48] Histidine is an essential aminoacid that has 
the imidazole moiety. Imidazole is also structurally present in histamine, a 
neurotransmitter. Imidazole has an extremely important role in metalloproteins, as it 
acts as a ligand to bind metal ions to their specific sites, as illustrated in the previous 
section (Figure 1.3).  
Many medications contain an imidazole moiety. Metronidazole, for example, is 
a widely used antibiotics which is in the list of the World Health Organization of 
essential medicines.[49] Imidazoles are employed as antifungal agents due to their 
their activity over the enzyme responsible for ergosterol synthesis in these 
organisms. Low levels of ergosterol in fungi result in fungal membrane disruption.[50] 
A recent report showed that imidazole is the seventh most frequent N-heterocycle 
present in the structure of U.S. approved drugs and benzimidazole is at the fifteenth 
position.[51] 
 Tetrazoles contain the maximally possible number of nitrogen atoms in a five 
membered-ring and have aromatic character.[52] It is less basic than imidazole and 
pyridine. Even though the tetrazole ring is not found in nature, it is now used as an 
isosteric (different functional groups that have similar physicochemical and biological 
properties) replacement for the carboxylic acid functional group in drug 
22 
 
 
 
development.[53] Tetrazoles have found applications in clinically used antibacterial 
and antihypertensive agents.[51]  
 Thiophene is not an N-heterocycle, but a sulfur-containing five-membered 
aromatic ring. This molecule is widely used as a building-block for drugs, as it is 
isosteric with benzene (also with pyrrole and furan). However, the presence of the 
sulfur atom makes it an electron-rich aromatic system, in a way that thiophene-based 
drugs may have a different metabolism than benzene derivatives.[54] Many 
commercial drugs already in use contain the thiophene moiety and many studies are 
currently performed to explore its bioactivity.[55] 
 Pyridine, pyrazine and pyrimidine are six-membered aromatic heterocycles 
and their derivatives are present in biomolecules or used as building-blocks in the 
development of new drugs. The pyridine ring is present in vitamins B3 and B6. 
Pyridine ranked second as the most frequent nitrogen heterocycles in U.S. Food and 
Drug Administration (FDA) approved drugs. This heterocycle is usually substituted at 
position 2, but even pentasubstitution of the ring is found in clinically used 
compounds.[51] 
 The pyrimidine ring ranked tenth in the same study.[51] Most of the pyrimidine 
drugs are substituted at position 2, probably due to the greater reactivity of this site. 
Pyrazine was not present at the top 24 nitrogen heterocycles of the FDA approved 
drugs[51], even though simple derivatives from this molecule are clinically used. As an 
example, pyrazinamide is used in combination with other drugs to treat 
tuberculosis.[56] 
Different combinations of these heterocycles in a single structure may lead to 
ligands with interesting coordination chemistry and biological properties. The 
proposed molecules of study in this dissertation are shown in Figure 1.5.  
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Figure 1.5. The ligands of interest of this dissertation. On the first row: 2-(imidazole-
2-yl)heteroaryl ligands, where heteroaryl = (a) pyridine (impy), (b) pyrazine (impz), (c) 
pyrimidine (impm) or (d) thiophene (thim). On the second row: the tetrazolic (e) 2-
(tetrazole-5-yl)pyridine (tzpy) and (f) 2,6-di(tetrazol-5-yl)pyridine (ditzpy) ligands. 
 
1.4. Objectives and dissertation presentation  
 
 The objectives of this work are to synthesize imidazolic and tetrazolic N-
heterocyclic ligands, study the influence of the different ligands on the chemical, 
structural and spectroscopic properties of their copper(II) coordination complexes and 
to test the bioactivity of the synthesized molecules over selected bacteria and fungi. 
 
 This text is divided in six chapters, including this Introduction.  
 Chapter 2 discusses the crystallographic data of three of the proposed ligands. 
Molecular structure and supramolecular interactions are discussed. Appendix A 
reports additional information on the usual spectroscopic characterization of these 
ligands and bond lengths and angles obtained from the structure determination.  
 Chapter 3 reports the synthesis and characterization, including crystal 
structure, of the novel copper complex [CuCl2(thim)2] with one of the proposed 
imidazolic ligands that also contains thiophene (thim). Biophysical experiments were 
performed in order to evaluate the possible mode of interaction of this complex with 
calf-thymus DNA. Antifungal activity was evaluated by the disc diffusion method. 
Additional information about ligand characterization, spectroscopic data and bond 
lengths and angles of this complex can be found in Appendix B. 
24 
 
 
 
 Chapter 4 reports a discussion on copper(II) complexes with impy, impz and 
impm ligands. Spectroscopic, diffraction and molecular modeling studies were 
performed to either assess their similarity in coordination mode or their differences in 
chemical properties, thus highlighting the effect of the ligand structure. Both the 
antibacterial and the antifungal activity of the complexes were evaluated. Additional 
spectroscopic data from the ligands, molecular modeling and crystal structures can 
be found in Appendix C. 
 Chapter 5 brings a general discussion on the chemical, crystallographic, 
spectroscopic and biological properties from the molecules studied in this 
dissertation, concludes this work and presents perspectives. 
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Chapter 2 
 
 
Crystal structures of three N-heterocylic ligands: 2-
(imidazole-2-yl)pyrazine, 2-(tetrazole-5-yl)pyridine and 2,6-
di(tetrazol-5-yl)pyridine 
 
 
The content of this chapter is an adaptation of an article in preparation by our 
research group, which includes the syntheses and characterization of several 2-
(imidazole-2-yl)heteroaryl and 2-(tetrazole-5-yl)heteroaryl ligands.  
My contribution to this work was partial spectroscopic and chemical 
characterization of the title ligands, obtention of single crystals from the title 
compounds of this chapter and description of their crystal structures. NMR and mass 
spectra of the title compounds are discussed in supporting information of this chapter 
(Appendix A), as these results have already been reported.[57–59] 
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2.1. Introduction 
 
 N-heterocyclic molecules have long been explored as ligands in coordination 
chemistry. The intermediate acid-base character of nitrogen allows it to coordinate a 
variety of metals, thus leading to a variety of molecular architectures. 
Among the five-membered nitrogen-containing heterocycles, imidazole and 
tetrazole are vastly reported for the formation of compounds with promising 
properties. Imidazole is a diazole and heterocyclic containing both an amino and 
imino nitrogen groups.[48] This ring is found in nature in histidine (an essential 
aminoacid), in histamine and in many alkaloids. Tetrazoles contain the maximally 
possible number of nitrogen atoms in a five membered-ring and have aromatic 
character.[52] This ring is not found in nature, though they are studied as carboxylic 
acid isosters in drug development.[53]  
Besides the coordinating ability of nitrogen of imidazoles and tetrazoles, these 
rings can be either protonated or deprotonated. Protonation results in the decrease of 
electronic density over all atoms within these rings, while deprotonation leads to the 
opposite effect.[52] This possible tailoring of electronic density by protonation 
deprotonation can be useful for the planning and development of coordination 
polymers and polynuclear complexes with applications in materials chemistry[60–62], 
bioinorganic[63] and catalysis[64].  
Substitution of these molecules leads to a broad variety of ligands which can 
be systematically studied on their coordination properties. In particular, combining the 
imidazole and tetrazole rings with other N-heterocycles classically studied in 
coordination chemistry, such as pyridine and pyrazine, can lead to assymetric ligands 
with different properties from bipyridine and phenantroline, for example. 
The synthetic procedures for the preparation of 2-substituted imidazoles or 5-
substituted tetrazole molecules are quite diverse and well-established. In the paper 
by Voss et al, 2-substituted imidazoles are synthesized from nitriles, by a one-pot 
methodology.[59] The synthesis of 5-substituted tetrazoles has been recently 
reviewed[65] and highlights the classical method of Finnegan[66], which uses a proton-
mediated synthesis and the cleaner method by Sharpless[67,68], which is mediated by 
zinc bromide. Characterization of the synthesized molecules in such articles is 
usually achieved by chemical and spectroscopical analyses. 
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However, characterization by diffraction is usually not reported due to the 
difficulty of single crystal obtention, so crystallographic data are not as vast. The 
evaluation of crystal structures allows the unambiguous determination of the 
molecular structure in the solid state and the obtention of information not as easily 
obtained by spectroscopic or chemical techniques, such as the types of 
intermolecular interactions and packing.  
 Moreover, the determination of crystal structures of a class of molecules 
allows the identification of hydrogen bonds patterns, as well as which type of 
aromatic-aromatic or π - π interactions governs crystal packing in these compounds. 
This is of fundamental importance for the rational development of supramolecular 
chemistry by tailoring and predicting novel crystal structures.[69] 
In this work, we report the crystal structures and present a systematic 
discussion about the intermolecular interactions of one imidazole-substituted 
molecule, 2-(imidazole-2-yl)pyrazine, and two tetrazole-substituted molecules 2-
(tetrazole-5-yl)pyridine and 2,6-di(tetrazol-5-yl)pyridine. These structures are among 
the first examples of crystal data available for 2-(imidazole-2-yl)heteroaryl and 2-
(tetrazole-5-yl)heteroaryl molecules our research group is interested in. 
 
2.2. Experimental Section  
 
2.2.1. Materials and Methods 
 
2-Pyridinecarbonitrile (99%), 2-pyrazinecarbonitrile and (99%), 2,6-
pyridinedicarbonitrile (97%), and sodium azide (99%), aminoacetaldehyde dimethyl 
and diethyl acetals (both 99% purity) were purchased from Sigma-Aldrich. were 
purchased  and Lithium chloride (99%) was purchased from Merck. Ammonium 
chloride (99.5%) was purchased from Synth (Brazil). All other reagents and solvents 
were used as received, without further purification.  
Elemental analyses were performed on a Perkin Elmer 2400 CHNS/O 
Analyzer. The 1H NMR spectra of the ligands were recorded in DMSO-d6, in a Bruker 
Avance III 500 MHz (11.7 T) spectrometer. Electrospray ionization mass 
spectrometry (ESI-MS) measurements were carried out using a Waters Quattro Micro 
API. The molecules were analyzed in a 1:1 methanol:water solution with addition of 
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0.10% (v/v) formic acid . Each solution was directly infused into the instrument’s ESI 
source and analysed in the positive mode, with capillary potential of 3.00 kV, trap 
potential of 2 kV, source temperature of 150 oC and nitrogen gas for desolvation. 
 
2.2.2. Synthesis 
 
2-(Imidazol-2-yl)pyrazine (impz) This ligand was synthesized according to the 
procedure reported by Voss, et al.[59] 0.90 mL (10 mmol) of 2-pyrazinecarbonitrile, 10 
mL MeOH and 0.38 mL (1 mmol) of a 30% solution of NaOMe in MeOH were added 
to a 100 mL round-bottom flask. The mixture was stirred for 30 minutes at room 
temperature. 1.45 mL (10 mmol) of aminoacetaldehyde diethyl acetal followed by 1.2 
mL of AcOH were added dropwise to the mixture and stirred for 1 hour at 50°C. 
Afterwards, the mixture was left to cool at room temperature, 20 mL of MeOH and 5 
mL of HCl 6 mol·L−1 were added and the resulting mixture was heated under reflux 
for 5 hours. The solution was evaporated to dryness, resolubilised in 15 mL of water 
and extracted with 3 × 5 mL of Et2O, resulting in a deep brown solution. The pH was 
adjusted to 8-9 with a NaOH 2 mol·L−1 solution, then the volume was reduced to 
favor the product precipitation. The dark brown product was filtered and washed with 
Et2O. To remove unwanted salt, the resulting powder was transferred to an 
Erlenmeyer. 20 mL of methanol were added and the system was heated to almost 
boiling. The hot solution was transferred to a flask and rotaevaporated to obtain the 
ligand as a dark brown powder. Yield 66 %. Anal. Calc. for C7H6N4 (%): C 57.53; H 
4.14; N 38.34. Found: C 57.63; H 4.16; N 38.14. 1H NMR (500 MHz, DMSO-d6): δ 
7.176 (br s, 1H), 7.351 (br s, 1H), 8.606 (d, 1H, J = 2.5 Hz), 8.659 (dd, 1H, J = 0.5, 
1.5 Hz), 9.252 (d, 1H, J = 1.5 Hz), 13.060 (br). MS (ESI-(+)) (m/z): calcd for C7H6N4 
[M+H+]+: 147.1, found: 147.1. Single crystals of impz were obtained by slow 
evaporation of a hot methanolic solution of this ligand to dryness. 
 
2-(tetrazole-5-yl)pyridine (tzpy) This ligand was synthesized according to the 
procedure reported by Bond, et al.[57] To a three-neck round bottom bound were 
added 1.05 g (10 mmol) of 2-pyridinecarbonitrile, 1.43 g (22 mmol) of sodium azide, 
1.18 g (22 mmol) of ammonium chloride and 0.31 g (7 mmol) of lithium chloride in 
anhydrous dimethylformamide (10 mL). This mixture was stirred for 10 h at 110 oC 
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under argon gas flux. After the reaction time, the suspension consisting of inorganic 
salts and yellow solution of the ligand was separated by filtration. The yellow solution 
was rotaevaporated to remove DMF and a yellow oil was obtained. To the oil were 50 
mL of water and 0.75 mL of concentrated HCl, which led to the precipitation of a 
white solid. The product was isolated by filtration in a Buchner funnel, washed with 
cold water and dried under vacuum. Recrystallization in ethanol afforded white 
needles of the product. Yield 46 %. Anal. Calc. for C6H5N5 (%): C 48.98; H 3.42; N 
47.70. Found: C 48.70; H 3.25; N 47.31. 1H NMR (500 MHz, DMSO-d6): δ 7.654 
(ddd, 1H, J = 1.0, 5.0, 7.5 Hz), 8.110 (td, 1.5, 8.0 Hz), 8.246 (d, 1H, J = 7.5 Hz), 
8.817 (d, 1H, J = 4.5 Hz. MS (ESI-(+)) (m/z): calcd for C6H5N5 [M+H
+]+: 148.1, found: 
148.1. Recrystallization of the initial powder in ethanol led to the formation of needles 
unsuitable for diffraction. After leaving the needles in contact with the ethanolic 
solution overnight, block-shaped crystals suitable for diffraction appeared.  
 
2,6-di(tetrazol-5-yl)pyridine (ditzpy) This ligand was synthesized according to the 
procedure reported by Fleming, et al.[58] To a three-neck round bottom bound were 
added 1.20 g (10 mmol) of 2,6-pyridinedicarbonitrile, 1.45 g (21.5 mmol) of sodium 
azide, 1.10 g (21.5 mmol) of ammonium chloride and 0.30 g (7 mmol) of lithium 
chloride in anhydrous dimethylformamide (20 mL). This mixture was stirred for 10 h 
at 110 oC under argon gas flux. After the reaction time, the suspension consisting of 
inorganic salts and yellow solution of the ligand was separated by filtration. The 
yellow solution was rotaevaporated to remove DMF and a dark yellow oil was 
obtained. To the oil were 40 mL of water and 0.5 mL of concentrated HCl, which led 
to the precipitation of a white solid. The product was isolated by filtration in a Buchner 
funnel, washed with cold water and dried under vacuum. It was obtained as a white 
powder. Yield 33 %. Anal. Calc. for C7H5N9 (%): C 39.07; H 2.34; N 58.58. Found: C 
38.59; H 2.03; N 56.94. A discussion about 1H NMR of this ligand is given in 
Appendix A. MS (ESI-(+)) (m/z): calcd for C7H5N9 [M+H
+]+: 216.1, found: 216.3. 
Crystallization of a small amount of this ligand was achieved by dissolving it in hot 
methanol (2 mL) and adding a few drops of water. The cooling of this mixture led to 
the formation of single crystals suitable for diffraction. 
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2.2.3. Single crystal X-ray diffraction 
 
Data collection for all three molecules was performed with a Bruker Apex II CCD 
diffractometer with graphite monochromated Mo – Kα ( = 0.71703 Å) or Cu – Kα ( = 
1.54178 Å) radiation. Accurate unit cell dimensions and orientation matrices were 
determined by least squares refinement of the reflections obtained by θ-χ scans. The 
data were indexed and scaled with the ApexII Suite [APEX2 v2014.1-1 (Bruker AXS), 
SAINT V8.34A (Bruker AXS Inc., 2013)]. Bruker Saint and Bruker Sadabs were used 
to integrate and for scaling of data, respectively.  
Using Olex2[70], the structure was solved with the ShelXT[71] structure solution 
program using Direct Methods and refined with the ShelXL[72] by a full-matrix least-
squares technique on F2. All non-hydrogen atoms were refined anisotropically. The 
hydrogen atoms in the compound were added to the structure in idealized positions, 
with the exception of the atom involved with the formation of a zwitterionic structure in 
tzpy (more discussion on item 2.3.1), and further refined according to the riding 
model; molecular graphics: OLEX2[70]; software was used to prepare material for 
publication. 
Searches in the Cambridge Structure Database (CSD), version 5.36, were 
performed using the Conquest software (version 1.17) and R < 0.1 and no powder 
data as restraints. 
 
2.3. Results and discussion 
 
2.3.1. Crystallographic discussion  
 
The chemical structures of the ligands solved by diffraction revealed the 
formation of either the imidazole or tetrazole rings, as seen in Figure 2.1. The 
crystallographic data is presented in Table 2.1. 
All the three reported molecules crystallized in the monoclinic crystal system, 
in space groups P 21/ c for impz and tzpy and in Cc for ditzpy. The assymetric unit of 
impz and ditzpy is described by one molecule, whereas that of tzpy is described by 
two, with no solvent molecule present in any of the structures. All bond lengths 
observed in the three ligands are in agreement with those found for the 
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corresponding pyrazine, pyridine, imidazole and tetrazole rings, as evaluated from 
the CSD.[73,74]  
Some of the important bond lengths and angles can be found in Tables A.1 to 
A.3 of Appendix A. An analysis of the angles between the planes of the rings indicate 
they are almost coplanar in the crystals of all ligands, as reported in Table 2.2.  
 
 
Figure 2.1. View of (a) impz, (b) one of the two tzpy molecules that describe its 
assymetric unit and (c) ditzpy. Atomic displacement ellipsoids are at the 50% 
probability level. Hydrogen atoms are represented by white spheres and only those 
bound to nitrogen atoms are labeled, for clarity. 
 
 The solved tzpy structure (Figure 2.1 (b)) shows that it is a zwitterion, because 
both tetrazolate and pyridinium ions are present within the same structure. This fact 
was attested by the presence of electronic density matching a hydrogen atom H1 
nearer N1 from the pyridine ring during refinement, though it is seen that H1 is 
involved in an intramolecular hydrogen bonding with the N2 atom from the tetrazole 
ring (see Figure 2.2). Moreover, the tzpy zwitterion is involved in strong 
intermolecular hydrogen bonding between two molecules, which leads to the 
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formation of dimers and probably to easier packing in the crystal, as also shown in 
Figure 2.2. 
 
Table 2.1. Crystallographic data of impz, tzpy and ditzpy structures. 
Compound impz tzpy ditzpy 
Empirical formula C7H6N4 C6H5N5 C7H5N9 
Molecular weight 
(g·mol
-1
) 
146.16 147.15 215.20 
Temperature (K) 296 150 150 
Wavelength (Å) Mo - Kα 0.71073 Cu - Kα 1.54178 Mo - Kα 0.71073 
Crystal system Monoclinic Monoclinic Monoclinic 
Space Group P 21/ c P 21/ c Cc 
a (Å) 7.2269 (18) 9.4676 (6) 8.532(3) 
b (Å) 9.650(2) 13.1565(8) 14.172(5) 
c (Å) 9.864(3) 10.1173(6) 7.507(5) 
α (
o
) 90 90 90 
β (
o
) 91.481(5) 97.107(4) 103.503(5) 
γ (
o
) 90 90 90 
V (Å
-3
) 687.7(7) 1250.5(1) 882.6(7) 
Z 4 8 4 
ρcalcd. (g cm
-3
) 1.412 1.563 1.620 
F(000) 304.0 440.0 608.0 
μ (mm
-1
) 0.095 0.901 0.118 
θ range (
o
) 3.52 - 26.82 5.54 - 68.26 2.84 - 26.07 
Data/ restraints/ 
parameters 
1143/0/100 1802/0/199 1499/ 2/ 151 
R1,wR2 [I > 2σ (I)] 0.0363, 0.0947 0.0463, 0.1346 0.0366, 0.0946 
Diff. peak and hole 
(e/Å
-3
) 
0.19 and -0.23 0.41 and -0.24 0.20 and -0.25 
Goodness-of-fit on F
2
 1.039 1.030 1.081 
  
The formation of this zwitterionic species for the tzpy molecule was not 
reported before in the literature, as the ligand characterization is usually performed 
only by spectroscopic techniques.[57,67] Another example of a pyridinium-tetrazolate 
zwitterion from the literature is the 1-methyl-4-(tetrazol-5-ate)pyridinium ion. 
However, this reported compound has an imposed pyridinium formation due to its 
methylation and it does not involve a proton.[75,76]  
 
Table 2.2. Angles between the least-squares adjusted planes of the rings. 
Angle in impz (o) Angle in tzpy (o) Angles in ditzpy (o) 
7.38(7) 3.74(9) 6.8(2)a and 7.0(2)b 
a = between the planes of the C1-N2-N1-N-9-N8 and C2-N3-C3-C7-C6-C5 rings; 
b = between the planes of the C2-N3-C3-C7-C6-C5 and C4-N4-N7-N6-N5 rings. 
33 
 
 
 
 
Figure 2.2. Intra (black dashed line) and intermolecular (red dashed line) hydrogen 
bonding in tzpy which leads to the formation of dimers in this crystal structure. 
 
2.3.2. Supramolecular interactions 
 
The supramolecular structure of impz involves the formation of a one-
dimensional network of strong[77] hydrogen bonding involving imidazole atoms 
N3-H3···N1i [H···A 2.01 Å, A···D 2.8257(18) Å, < (DHA) 158.0˚ (i = x, 1/2 - y, 1/2 + 
z)], as shown in Figure 2.3. Weaker and longer interactions[78] involving carbon atoms 
from imidazole and nitrogen atoms from pyrazine contribute to the formation of the 
three-dimensional array of the crystal, as described by: C1-H1···N4ii [H···A 2.62 Å, 
A···D 3.407(2) Å, < (DHA) 142˚ (ii = 2 - x, 1/2 + y, 1/2 - z)], C6-H6···N2iii [H···A 2.53 
Å, A···D 3.429(2) Å, < (DHA) 162.0˚ (iii = 1 + x, 1/2 - y, 1/2 + z)] and C4-H4···N4iv 
[H···A 2.57 Å, A···D 3.417(2) Å, < (DHA) 152˚ (iv = x, 1/2 - y, - 1/2 + z)] (see Figure 
2.3). Hydrogen bonds are of fundamental importance in the chemistry of imidazoles 
and tetrazoles. As an example, the substitution of the hydrogen atom from the amino 
group by a methyl group lowers the melting point of free imidazole by almost 100 
oC.[48] 
Another important intermolecular interaction present in impz involves a “point-
to-face” π interaction.[69] From Figure 2.3, it can be seen that the imidazole ring acts 
as electron donor to an electron-deficient hydrogen atom H5 from an adjacent 
pyrazine ring. This interaction can be described by symmetry as C5-H5···CGv 
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[H···CG 2.51 Å (v = 1 - x, - 1/2 + y, 1/2 - z)], where CG is the center of gravity of the 
imidazole ring. 
 
 
Figure 2.3. Intermolecular interactions present in impz crystal structure. The 
description of symmetry labels is given in the text. 
  
 All nitrogen atoms from the tetrazolic ring in tzpy are involved in either 
C-H···N[78] or N-H···N interactions. Since two tzpy molecules describe the assymetric 
unit of the structure, the hydrogen bonds that form the dimers are not equivalent, but 
are described by the same symmetry operation: N1-H1···N7vi [H···A 2.00 Å, A···D 
2.810(2) Å, < (DHA) 153˚ (vi = 1 - x, 1 - y, -z)] and N6-H(6A)···N2vi [H···A 1.99 Å, 
A···D 2.808(2) Å, < (DHA) 153˚]. These hydrogen bonds were shown in Figure 2.2. 
 As opposite to impz, no point-to-face π interaction is observed in tzpy, which 
might indicate the pyrazine hydrogen H5 has a greater partial positive charge than 
the hydrogen atoms in the pyridine ring. However, the interactions described as offset 
π··· π[69] are present (see Figure 2.4) and are responsible for the stacking of the 
molecules. 
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Figure 2.4. Representation of offset π··· π interactions in tzpy molecule. 
 
 An infinite one-dimensional chain of ditzpy molecules is created by two strong 
hydrogen bonds: N2-H2···N6vii [H···A 1.98 Å, A···D 2.810(4) Å, < (DHA) 164˚ (vii = 
1/2 + x, 1/2 - y, 1/2 + z)] and N5-H5···N4viii [H···A 2.54 Å, A···D 2.832(5) Å, < (DHA) 
175˚ (viii = -1/2 + x, 1/2 - y, -1/2 + z)] (see Figure 2.5).  
 Two weaker[78] C-H···N interaction involving the carbon atoms from the 
pyridine ring contribute to the expansion of the lattice, as described by 
C5-H5(A)···N8ix [H···A 2.41 Å, A···D 3.288(5) Å, < (DHA) 154˚ (ix = -1/2 + x, 3/2 - y, -
1/2 + z)] and C7-H7···N7viii [H···A 2.53 Å, A···D 3.463(5) Å, < (DHA) 166˚] (Figure 
2.5). As observed in tzpy, offset π···π interactions are responsible for the formation of 
the three-dimensional crystal structure of ditzpy. 
No deviations of bond length or angle was observed in the three structures. 
However, some tendencies must be highlighted. The ring planarity is quite relevant 
for the molecular packing, probably due to the directional character of the π···π 
interactions observed in the ligands. Moreover, in both imidazole and tetrazole 
molecules, hydrogen bonding is essential for the network formation, which can be 
further explored in the design of new ligands and supramolecular systems. 
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Figure 2.5. Intermolecular interactions present in ditzpy. The description of the 
symmetry labels is given in the text. Red dashed lines represent interactions already 
described from the central molecule. 
 
2.4. Partial conclusions 
 
 Three N-heterocyclic molecules have been synthesized and characterized. X-
ray single crystal diffraction provided a detailed set of data about these compounds, 
which cannot be usually attained by routine spectroscopic and chemical techniques, 
as reported in the literature.  
 The supramolecular structures of all ligands have strong N-H···N hydrogen 
bonds between either imidazole or tetrazole rings as major factors of network 
formation. Weaker C-H···N interactions show a minor contribution for the lattice 
formation. The type of π interactions was different in the structures. The imidazolic 
ligand impz had a point-to-face interaction, as opposite to the more frequent offset 
stacking observed in the tetrazolic ligands.  
  
37 
 
 
 
Chapter 3 
 
 
A copper(II) complex with 2,2-thiophen-yl-imidazole: 
synthesis, spectroscopic characterization, X-ray 
crystallographic studies, interactions with calf-thymus DNA 
and antifungal activity 
 
 
The content of this chapter is an adaptation of the article entitled “Copper(II), 
palladium(II) and platinum(II) complexes with 2,2-thiophen-yl-imidazole: synthesis, 
spectroscopic characterization, X-ray crystallographic studies and interactions with 
calf-thymus DNA” by Nina T. Zanvettor, Douglas H. Nakahata, Raphael E. F. de 
Paiva, Marcos A. Ribeiro, Alexandre Cuin, Pedro P. Corbi and André L. B. Formiga. 
This content was reprinted with permission from Inorganica Chimica Acta. 
Copyright 2016. Elsevier Limited. The license to use this article (full paper) in this 
dissertation is found in Appendix D. 
 
Reference: Inorg. Chim. Acta 2016, 443, 304-315. 
 
My contribution to this work was in the synthesis and characterization of the 
copper(II) complex, participation on the biophysical experiments of interaction of the 
compounds with calf-thymus DNA and partial writing of the publication. The 
antifungal activity assay was not included in the published article. 
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3.1. Introduction 
 
 Metal ions have been explored in medicine for a long time. According to the 
literature, the vast application of metals in medicine includes antimicrobial and 
anticancer compounds, antiarthritic agents, enzymatic inhibitors, and others.[79,80] 
Nowadays, the platinum compounds, such as cisplatin (cis-[PtCl2(NH3)2]), constitute 
one of the most widely used anticancer drugs.[79,81,82] Silver compounds, on the other 
hand, have been applied in the treatment of bacterial infections in burns and wounds, 
and also in other medical applications, including dental work and catheters[14,83], while 
gold complexes, such as auranofin and miochrisine, have been extensively used for 
the treatment of rheumatoid arthritis.[79]  
 Cisplatin was one of the first metallodrugs broadly employed in medicine. It 
was approved in 1978 by the FDA (Food and Drug Administration, USA) for cancer 
treatment. The first pharmacological activities of cisplatin were reported by 
Rosenberg et al.[2,3] In the late of the 1960’s, Rosenberg evaluated the activity of this 
compound over Sarcoma 180 solid tumors implanted in mice[3], which resulted in a 
high cure rate. Today, cisplatin is still considered one of the most effective antitumor 
agents, especially for testicular cancer, for which the cure rate exceeds 90%.[84] 
Cisplatin is also considered in the treatment of head and neck, lung, colorectal and 
ovarian cancers.[81]  
 Nevertheless, cisplatin is also known for its renal and gastrointestinal 
toxicities.[7] Besides the side effects, the inherent or acquired resistance of some 
tumors to cisplatin also restricts its use.[84] These effects stimulated the search for 
new platinum-based chemotherapeutic drugs, which resulted in the approval of 
carboplatin in 1989 by FDA.[84] This drug has shown to have reduced collateral 
effects, mainly concerning its nephrotoxicity, neurotoxicity and ototoxicity.[84]  
 The search of new chemotherapeutic agents based on platinum led to the 
approval of oxaliplatin (worldwide), nedaplatin (China) and lobaplatin (Japan).[84] 
These platinum complexes derived from cisplatin are all of cis- geometry with two 
stable amine ligands and two labile ones. When these compounds enter inside the 
cells they are first hydrolyzed losing the labile ligands, and thus bind to DNA through 
the imidazole group of adjacent guanines. The interaction with DNA forms an 
intrastrand crosslink, which alters DNA structure blocking cell replication.[84] 
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 Copper(II) complexes have also been investigated for their biological 
properties assuming that, since it is an endogenous element, it may be less toxic to 
normal cells. Copper(II) ions and their complexes are generally associated to redox 
processes. Copper enzymes, such as superoxide dismutase, are examples of copper 
compounds in the human body that act in redox reactions.[18] The coordination 
chemistry of copper(II) is quite distinct from palladium(II) and platinum(II), giving rise 
to different modes of action.[18]  
 In the field of medicinal chemistry, copper(II) complexes have received great 
attention due to their antitumor[18,40,41] and antibacterial activities.[37,85] However, the 
complete elucidation of their mechanisms of action is still in progress.[18] Both 
covalent and non-covalent (intercalation, groove binding or electrostatic) modes of 
interaction with DNA have been reported for copper(II) complexes in the 
literature.[35,85] Copper complexes with modulated redox potential can also be related 
to the generation of reactive oxygen species (ROS), which can further damage DNA 
and blockage cell proliferation.[18,41] 
 Imidazole is a five-membered aromatic heterocyclic diazole. It is found in 
several biomolecules, such as histamine, vitamin B12, DNA, proteins and 
hemoglobin.[86] Imidazole exists in two tautomeric forms and exhibits a considerable 
Lewis basicity. It also participates in intermolecular interactions such as hydrogen 
bonding.[86] Due to these characteristics, several compounds based on imidazole are 
used as drugs, such as antitumoral, antibacterial, anti-fungal, antiparasitic, 
antihistaminic, antineuropathic and antihypertensive agents.[86]  
 Copper(II) complexes with imidazole derivatives that present pharmacological 
activity are under investigation.[87–90] Copper(II) complexes with benzimidazole 
derivatives have shown to interact with DNA and proteins and induce a significant 
cytotoxicity against cervical cancer cells.[87] 
 Thiophene is a five-membered, sulfur-containing heteroaromatic ring with 
remarkable pharmacological application. The biological activities of thiophene 
derivatives were more recently investigated, as this group is not usually found in 
living organisms with rare exceptions.[91] Nowadays, it is used as a building block in 
many drugs.[55,92] Examples of drugs with thiophene moieties are the antimicrobial 
cefoxitin, the anticancer raltitrexed, the anti-inflammatory tenoxicam and the 
antihypertensive tiamenidine.[92] Novel thiophene derived compounds with biological 
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activities are under investigation and new compounds with anticancer,[55,91] anti-
inflammatory[93] and antimalarial activity[94] were recently synthesized.  
 Here we describe the synthesis, structural characterization and studies of 
interaction with calf-thymus DNA of a new copper(II) complex with the 2,2-thiophen-yl 
imidazole (thim) ligand.  
 
3.2. Experimental Section 
 
3.2.1. Materials and methods 
 
2 –thiophenecarbonitrile 99%, aminoacetaldehyde dimethyl acetal 99 % and DNA 
sodium salt from calf-thymus type I 42% of guanine-citosine were purchased from 
Sigma-Aldrich Laboratories. CuCl2·2H2O 99% and NaClO4·H2O 98.0 – 102.0 were 
purchased from Vetec – Sigma (Brazil). HCl 36.5 – 38 %, NaOH 97 %, glacial acetic 
acid, ethanol and methanol 99.8 % were purchased from Synth (Brazil). Metallic 
sodium was purchased from Riedel-de Haen. All other reagents and solvents were 
used as received, without further purification. Elemental analyses were performed on 
a Perkin Elmer 2400 CHNS/O Analyzer. Electronic spectra in the 190-1100 nm range 
were acquired by using a 1.0 cm quartz cuvette in a diode array HP8453 UV/Visible 
absorption spectrophotometer. Infrared spectroscopy measurements were performed 
on an Agilent Cary 630 FTIR spectrometer, using the Attenuated Total Reflectance 
(ATR) method, with a diamond cell. Spectra were recorded from 4000-400 cm-1, with 
64 scans and resolution of 4 cm-1. The 1H NMR spectra of thim was recorded in a 
Bruker Avance III 500 MHz (11.7 T) spectrometer. Electrospray ionization mass 
spectrometry (ESI-MS) measurements were carried out using a Waters Quattro Micro 
API. Samples were evaluated in the positive mode. [CuCl2(thim)2] was analyzed in a 
1:1 acetonitrile:water with 0.10% (v/v) formic acid. Each solution was directly infused 
into the instrument’s ESI source and analysed in the positive mode, with capillary 
potential of 3 kV, trap potential of 2 kV, source temperature of 150 oC and nitrogen 
gas for desolvation. Fluorescence measurements were performed on a Cary Eclipse 
fluorescence spectrophotometer. Excitation and emission slits were of 5 nm and 
scanning speed was set to medium. A quartz cuvette of four clear windows and 
optical path length of 1 cm was used. Excitation wavelength was set as 525 nm and 
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emission window was from 540 to 750 nm. Circular dichroism measurements were 
performed in a Jasco J-720 spectrophotometer, from 200 to 260 nm, in quartz 
cuvettes of 0.5 cm of optical path length. Single crystal X-ray diffraction was 
performed with a Bruker Apex II CCD diffractometer with graphite monochromated 
Mo - Kα ( = 0.71703 Å) radiation. More information about refinement and data 
treatment can be found in Chapter 2 – subitem 2.2.3. All crystallographic data for this 
paper are deposited with the Cambridge Crystallographic Data Centre #1403268, 
#1406385 and #1406386. 
 
3.2.2. Synthesis 
 
thim: The synthesis of the ligand was carried out following a reported method in the 
literature.[59] This is a one-pot method for the preparation of heteroaryl-2-imidazoles 
from nitriles. Yield (Calcd. from the aminoacetal): 0.701 g, 58 %. Anal. Calcd. for 
C7H6N2S (%): C, 55.97; H, 4.03; N, 18.65. Found (%): C, 56.42; H, 4.18; N, 18.66. 
1H 
NMR (500 MHz, DMSO-d6): δ 6.9 and 7.1 (br, 2H), 7.107 (dd, 1H, J = 3.6, 4.8 Hz), 
7.488 (dd, 1.2, 4.2 Hz), 7.507 (dd, 1H, J = 1.2, 3.6 Hz), 12.5 (br, 1H) (for the 
spectrum, see Appendix B, Figure B.1). MS (ESI-(+)) (m/z): calcd for C7H6N2S 
[M+H+]+: 151.0, found: 151.1. This ligand is soluble in acid aqueous medium, 
methanol, ethanol, DMSO and DMF.  
 
[CuCl2(thim)2]: The copper(II) complex was synthesized by the reaction of an 
ethanolic CuCl2·2H2O solution (5.0·10
-4 mol, 10 mL) with an ethanolic solution of 
Thim (1.0·10-3 mol, 10 mL). The synthesis was carried out with stirring at room 
temperature. A reddish-brown solid slowly precipitated. After 4 hours of constant 
stirring the solid was collected by filtration, washed with a small amount of cold 
ethanol and dried in vacuum. Yield: 0.125 g, 58 %. Anal. Calcd. for 
[CuCl2C14H12N4S2] (%): C, 38.70; H, 2.78; N, 12.88. Found: C, 38.70; H, 2.96; N, 
12.83. MS (ESI-(+)) (m/z): calcd for [Cu(C7H6N2S)2]
+: 363.0, found: 363.3. The 
complex is quite soluble in methanol, DMSO and DMF. After 4 days of slow 
concentration of the ethanolic filtrate, single crystals suitable for X-ray diffraction were 
formed. 
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3.2.3. DFT calculations 
 
 All calculations were performed with the hybrid PBE0 functional[95] with the 
ORCA package (version 3.0.3)[96] using the RIJCOSX method[97] to calculate the 
exchange energy. Densities were optimized with a 10–8 au convergence criterion for 
the energy and a 10–5 gradient for the KS orbitals. The def2-TZVP basis set[98,99] was 
used for all atoms. Geometry optimizations were performed without symmetry 
constrains using a conjugate gradient with a 5 x 10–6 au convergence criterion for the 
energy and a 10–4 criterion for the RMS of the gradient. Geometries were confirmed 
as minima of the PES by calculation of the Hessian showing no imaginary 
frequencies. Harmonic frequencies were scaled using a factor of 0.9593[100] and 
vibrational spectra were simulated using lorentzian functions with 20 cm–1 full widths 
at half heights. 
 
3.2.4. DNA dialysis 
 
 Appropriate amount of calf-thymus (CT) DNA was dissolved in deionized 
water. It was dialyzed for 24 hours, using a membrane of 30000 Da cutoff in a 10 mM 
of NaClO4 aqueous solution.  The nucleic acid concentration was determined using 
UV-Vis spectroscopy, by considering a molar extinction coefficient of CT-DNA at 260 
nm of 6600 L·mol-1·cm-1. The DNA concentration in this stock solution was 
determined as 450 µM. 
 
3.2.5. Binding properties of compounds with DNA using UV-Vis spectroscopy 
 
 Solutions of compounds were dissolved in methanol and further diluted in a 10 
mM NaClO4 aqueous solution (final methanol volume was 4%) for an initial 
concentration of 20 µM. CT-DNA in 10 mM NaClO4 aqueous solution was added to 
the solutions of the compounds for different [DNA]/ [compound] ratios, ranging from 0 
to 7.0. 
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3.2.6 Competitive binding with ethidium bromide (ETBr) using fluorescence 
spectroscopy 
 
 Samples of CT-DNA (100 µM in 10 mM NaClO4 aqueous solution) were 
incubated with thim and [CuCl2(thim)2] with molar ratios ri = 0.10 and 0.20 for 24 
hours, at 37 oC. The spectra were recorded after successive additions of 2 µL 
aliquots of ethidium bromide (initial concentration of 0.50 mg·mL-1) prepared in 10 
mM NaClO4 aqueous solution. Spectra of pure CT-DNA with increasing concentration 
of ETBr and of pure ETBr were also recorded. Data were compared by taking the 
average of fluorescence intensity at 606 nm of three independent measurements as 
a function of ETBr concentration. 
 
3.2.7. Circular Dichroism (CD) spectroscopy 
 
 The compounds (methanolic stock solutions) were added to DNA solutions 
(100 µM, in 10 mM NaClO4 aqueous solution) for different [compound]/[DNA] ratios, 
from 0 to 0.30, and incubated at 37 oC for 24 hours. A CD spectrum of a sample with 
methanol at ratio = 0.30 was also prepared for control. The spectra were recorded 
with a scanning speed of 20 nm·min-1 and 8 accumulations.  
 
3.2.8. CT-DNA thermal denaturation – melting point determination 
 
 Samples of CT-DNA (100 µM, in 10 mM NaClO4 aqueous solution) were 
incubated with thim and [CuCl2(thim)2] (molar ratio of compound/ CT-DNA of 0.10; 
methanolic stock solutions) for 24 hours at 37 oC. The absorbance at 260 nm of each 
sample was recorded as a function of temperature in the range 30 oC - 94 oC. The 
temperature was controlled with a thermostated water bath, using a 2 oC·min-1 
heating rate. The spectra were recorded after 1 minute of thermal equilibrium at each 
temperature. All measurements were performed in triplicate. 
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3.2.9. Antifungal activity assay 
 
 Antifungal activities of [CuCl2(thim)2] were evaluated using the agar diffusion 
method. The tested yeasts were: Candida albicans: ATCC 26790, Fusarium 
moniliforme: ATCC 38159 and Trichophyton mentagrophytes: ATCC 11481. The 
base layer was obtained by addition of 20 mL of Agar Sabouraud (Difco) in Petri 
dishes of 20 x 150 mm. After solidification of this layer, 5 mL of saline solution with a 
concentration of 1 x 108 CFU·mL-1 (colony forming units) of the strains were added to 
obtain the seed layer. Wells of 5.0 mm of diameter were made in the agar, 20 μL of 
the treatment solutions (1 mg·mL-1) were placed in the wells. Amphotericin was used 
as positive control whereas ethanol/water (1:1 EtOH/H2O) solution was used as 
negative control. The dishes were incubated for 24 h at 37°C and the inhibition zones 
were measured (diameter and the space between the ring of the well and the 
beginning of fungi growth in millimeters). These experiments were performed in 
collaboration with Professor Dr. Marcelo Lancelloti and his research group 
(LABIOTEC) from the Biology Institute of UNICAMP. 
 
3.3. Results and Discussion 
 
3.3.1. Crystal structure of the Cu(II) complex 
 
[CuCl2(thim)2] crystallizes in the monoclinic space group P21/c with an 
asymmetric unit corresponding to half of the coordination formula [CuCl2(C7H6N2S)2]. 
The [CuCl2(thim)2] molecule is shown in Figure 3.1 and crystallographic data are 
presented in Table 3.1. The copper ion lies over the special position (1 1 0) with half 
occupancy. It is tetracoordinated by two imidazole nitrogens and two chlorides, 
resulting in a neutral complex. The Cu1-N10 bond distance, 1.9487(16) Å, is slightly 
shorter than the average value 1.970(17) Å found in CSD[74] for Cu-N in imidazole 
moieties, whereas the Cu1-Cl1 bond distance of 2.3036(5) Å is longer than those 
found in CSD for tetracoordinated copper(II) complexes (2.242(31) Å). The copper 
ion is perfectly located in the least square plane (rms=0 Å) defined by N10, N10 i, Cl1 
e Cl1i (I = -x, -y, -z). The long distance between Cu1 and S1 (3.0419(8) Å) is far from 
the average bond distance for a Cu-S (2.278(20) Å)[73] bond.  
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Figure 3.1. View of compound [CuCl2(thim)2]. Atomic displacement ellipsoids are at 
the 50% level. Hydrogen atoms are represented by open circles. 
 
 These observations are also in agreement with those found for a similar 
copper(II) complex containing benzimidazole.[101] When compared to the free 
imidazole ring[73] no significant differences were found, with the values varying within 
the experimental errors. Specifically, the C6-N10 bond (1.331(2) Å) has more double 
bond character than N7-C6 (1.347(2) Å). The bond distances in thiophene ring are in 
accordance with the related distances found in CSD. Moreover, both rings showed to 
be planar with least squares planes of 0.0041 Å and 0.0037 Å for thiophene and 
imidazole, respectively, where the planes deviated 14.03(12)˚ from each other. Bond 
distances and angles for [CuCl2(thim)2] are shown in Appendix B, Table B.1. 
 Short hydrogen bonds connect the coordination compounds, forming an 
infinite 2D chain motif through N7-H7···Cl1ii (H···A 2.33 Å, A···D 3.1728(17) Å, 
<(DHA) 165.1˚ (ii = -x, -1/2 + y, 1/2 - z). Two intermediate interactions arise between 
C8-H8···Cl1iii (H···A 2.82 Å, A···D 3.639(2) Å, < (DHA) 147.0˚, iii = x, -1/2 - y, -1/2 + 
z) and C2-H2… Cl1iv (iv = -1 + x, y, z) forming a 2D infinite chain, as shown in Figure 
3.2. The latter could be responsible to hold the thiophene group almost coplanar to 
the imidazole group. Distances between ring centroids are in the upper limit defined 
for π···π interactions (usually in the range 3.3 – 3.8 Å)[69], thus they are less relevant 
for the packing. The separation between the centroid defined by S1-C2-C3-C4-C5 
and N7-C6-N10-C9-C8 rings is 3.7106(13) Å and the ring planes are almost coplanar 
with 6.95(10)˚ from each other. 
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Table 3.1. Crystallographic data for [CuCl2(thim)2] crystal structure. 
Empirical formula C14H12Cl2CuN4S2 
Coordination formula [CuCl2(C7H6N2S)2] 
Molecular weight (g·mol-1) 434.84 
Temperature (K) 100(2) 
Wavelength (Å) Mo Kα – 0.71073 
Crystal system Monoclinic 
Space Group P21/c 
a (Å) 8.7424(13) 
b (Å) 12.9798(19) 
c (Å) 8.0922(12) 
α (o) 90 
β (o) 111.374(3) 
γ (o) 90 
V (Å-3) 855.1(2) 
Z 2 
ρcalcd. (g cm
-3) 1.697 
F(000) 442 
μ (mm-1) 1.836 
θ range (o) 2.50 - 30.02 
Reflections collected/ independent 13224/ 2504 (Rint = 0.0412) 
Data/ restraints/ parameters 2504 / 0 / 106 
R1,wR2 [I > 2σ (I)] 0.030, 0.067 
Diff. peak and hole (e/Å-3) 0.43 and -0.29 
Goodness-of-fit on F2 1.01 
CCDC number 1406385 
 
  
Figure 3.2. Hydrogen bonding pattern in [CuCl2(thim)2]. 
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3.3.2. Molecular modeling 
 
 The geometries of the Cu(II) complex was optimized using DFT with the hybrid 
PBE0 functional and a basis set of triple zeta quality for all atoms. Comparison 
between crystallographic data and DFT results show that geometries are well 
reproduced. Figure 3.3 shows the equilibrium geometry and Table 3.2 reports a 
comparison between experimental and calculated bond distances and angles. 
 
 
Figure 3.3. Equilibrium geometry and frontier Kohn-Sham orbitals obtained for 
[CuCl2(thim)2] by DFT calculations with PBE0/def2-TZVP. 
 
Table 3.2. Optimized bond lengths and angles of [CuCl2(thim)2] and comparison with 
experimental values. 
Bond length (Å) or 
angle (o) 
[CuCl2(thim)2] 
(experimental) 
Cu-N 2.0256 (1.9487(16)) 
Cu-Cl 2.2595 (2.3036(5)) 
N-Cu-N 179.33 (180.00) 
Cl-Cu-Cl 179.56 (180.00) 
S1-C5-C6-N10 42.4 (-13.8(2)) 
 
The main difference between crystal and DFT structures is the rotation of the 
thiophene rings in the complex. The S1-C5-C6-N10 torsion angles in the crystal 
structures is -13.8(2)º while it is predicted to be around -42º by DFT, thus a difference 
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of almost 30o. This can be explained by the absence of intermolecular interactions 
between two asymmetric units in the gas phase simulation. Moreover, this 
observation reinforces the previous one based on XRD that the long range Cu(II)···S 
interaction is not relevant. 
 Frontier Kohn-Sham orbitals for [CuCl2(thim)2] can be seen in Figure 3.3. As 
expected for a square planar d9 complex, the SOMO (Singly Occupied Molecular 
Orbital) has a contribution from the 3dx
2-y
2 orbital from copper. The LUMO is mainly a 
combination of the π* system of both thiophene ligands.  
 
3.3.3. FTIR spectroscopy 
 
 Powdered samples of thim and [CuCl2(thim)2] were analyzed by attenuated 
total reflectance Fourier-transform infrared spectroscopy (ATR-FTIR) and the full 
spectra can be found in Appendix B, Figure B.2. The band assignments were 
performed with the aid of DFT calculations for all species and the complete simulated 
spectra can also be found in Appendix B, Figure B.3. 
 The presence of a N-H···N hydrogen bond network in thim results in the large 
broadening of bands from approximately 3010 to 2500 cm-1.[59,102] The broadening of 
this band is not present in the spectra of the complexes, because this type of 
interaction does not occur in these molecules, as seen in the crystal structures for 
[CuCl2(thim)2]. The band at 3176 cm
-1 in the spectum of [CuCl2(thim)2] is assigned as 
the N-H stretching mode. 
 The most important differences between the spectra of free ligand and 
complexes can be found in the range 1600-1380 cm-1, where C=C and C=N 
stretching can be observed.[102] Figure 3.4 shows a comparison between 
experimental and simulated spectra in this region.  
Calculations show that the band at 1431 cm-1 for thim corresponds to the 
asymmetric stretching of the N=C-N bonds of the imidazole rings. After coordination 
the band shifts to higher wavenumbers for the complex. The shift is +22 cm-1 for 
[CuCl2(thim)2] and theoretical results predict shifts of +29 cm
-1, being in an excelent 
agreement with experimental values.  
The bands at 1518 and 1589 cm-1 for thim correspond, respectively, to the 
C=C stretching of the thiophene ring and the C-C stretching mode of the atoms that 
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connect the rings. Theoretical results predict that upon coordination their relative 
intensities are reversed as can be seen in Figure 3.4 (b). The same tendency is 
observed in the experimental spectra of [CuCl2(thim)2]. The predicted shift to higher 
wavenumbers for the C-C stretching mode of the atoms that connect the rings is not 
observed experimentally. This band appears in the spectra of the complex at 1585 
cm-1 and the small differences are probably due to the packing observed in the 
crystal structure which was not taken into account in calculations.  
 
 
Figure 3.4. Partial a) Experimental ATR-FTIR and b) simulated PBE0/def2-TZVP 
spectra of thim and [CuCl2(thim)2]. 
 
The C-S stetching mode is observed at 846 cm-1 in the ligand[102] and it is 
observed at 848 cm-1 in the spectrum of [CuCl2(thim)2] (see Figure B.1, Appendix B). 
This assignment was confirmed by DFT, which predicted the band to be at 839 cm-1 
for thim and at 843 cm-1 for the complex. The minor changes observed confirm that 
the sulfur atom of the thiophene ring is not involved in coordination, as it can be seen 
in the single crystal XRD structures.  
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3.3.4. Mass spectrometry 
 
 The mass spectrum of [CuCl2(thim)2] given in Figure 3.5 shows the signal of 
the protonated ligand at m/z 151.1 and also the species [Cu(I)(C7H6N2S)2]
+ at m/z 
363.3, whith matching isotopic pattern. Metal reduction is a widely occurring 
phenomenon in the electrospray process, especially for Cu(II) and Fe(III).[103,104] One 
hypothesis to explain Cu(II) reduction is that gaseous electrons produced by an 
electric discharge between the ESI capillary and the sampling cone can either reduce 
the metal ions on the surface of a droplet, or in the gas phase.[104] 
 
 
Figure 3.5. Mass spectrum of [CuCl2(thim)2]. 
 
 Neither [Cu(II)Cl(C7H6N2S)2]
+ (calculated m/z 398.9) nor [Cu(II)Cl2(C7H6N2S)2 
+ H]+ (calculated m/z 433.9) species were observed. The fact that thim acts as a 
monodentate ligand and does not chelate the metal ion probably contributes to the 
ease of metal reduction and chloride loss is favored in a water/ acetronitrile solution. 
Conductivity measurements of [CuCl2(thim)2] in pure methanol do indicate that this 
complex undergoes partial solvolysis, with the molar conductivity value (95.2 
S·cm2·mol-1) within the range of 1:1 electrolytes in this solvent.[105] Both methanol and 
water have a similar donor number (around 18)[106], so the behavior of the complex in 
both aqueous solution (used in mass spectrometry experiment) and in methanolic 
solution (for conductivity measurements) should be similar. 
 
3.3.5. UV – Visible spectroscopy and DNA interaction 
 
 The electronic spectra of a concentrated [CuCl2(thim)2] methanolic solution is 
given in Figure 3.6. The d-d transition of [CuCl2(thim)2] is observed as a broad band, 
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with low intensity and maximum at 768 nm. This is consistent with the fact that d-d 
transitions are prohibited by the Laporte selection rule. The blue-shift of the maximum 
observed for the d-d band when compared to CuCl2·2H2O dissolved in pure methanol 
(887 nm) is consistent with the stronger field induced by the ligand coordination. 
 
 
Figure 3.6. Normalized electronic spectra of methanolic [CuCl2(thim)2] and 
CuCl2·2H2O solutions. 
  
 The UV-Visible spectrum of [CuCl2(thim)2] was also recorded in the presence 
of increasing amounts of calf-thymus DNA (shown in Figure 3.7) as a first tool to 
evaluate its possible mode of interaction with DNA.[107–109] Bands in the range 200 - 
400 nm of the spectrum without added DNA are assigned to π  π* or n  π* 
transitions of the ligand. 
 If an intercalative binding mode were in action, both hypochromism and 
batochromism should be observed. Batochromism would result from the coupling of π 
orbitals from the ligand with π orbitals from the DNA base pairs, therefore decreasing 
the π  π* transition energy. However, the coupling orbital was already filled by 
electrons, so there is also a decrease in transition probabilities, so a concomitant 
hypochromism should be observed.[108,109] Neither of these phenomena were 
observed, which led us to exclude this type of interaction. 
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Figure 3.7. Electronic spectra of [CuCl2(thim)2] (20 µmol·L
-1) with increasing amounts 
of an aqueous solution of CT-DNA (10 µmol·L-1). The dashed line corresponds to the 
spectrum without DNA and solid lines are the spectra after DNA addition. 
  
3.3.6. Fluorescence Studies with Ethidium Bromide 
 
 Ethidium bromide (ETBr) is a fluorescent compound known to intercalate with 
DNA, with enhancement of its fluorescence.[107] The fluorescence at 606 nm of 
solutions containing the compounds and DNA in two molar ratios ([compound]/[DNA]) 
were evaluated with increasing concentrations of ETBr in a 10 mmol·L-1 NaClO4 
solution. 
 From Figure 3.8, it can be observed that the highest fluorescence intensity (FI) 
is seen for the solution containing ETBr and DNA and the lowest FI is seen for the 
solution with only ETBr and none of the compounds. This behavior is expected as 
ETBr has a much higher FI when it interacts with DNA due to decreased quenching 
of its excited state by water after intercalating into the hydrophobic environment of 
the DNA molecule.[110] 
All the compounds studied showed a reduced FI than the pure DNA solution 
with ETBr and a higher FI than the pure ETBr solution. Thim shows a higher FI than 
the complex. Also, thim does not show any considerable difference between the two 
molar ratios, indicating that the DNA is already saturated with thim in the low molar 
ratio. 
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The results show that thim and its Cu(II) complex interact with DNA 
considerably. Since the UV-Vis analyses indicated that the compounds do not 
intercalate with DNA, they probably have a mode of interaction that blocks the 
interaction of ETBr with DNA, but with no intercalation. Also, since thim shows the 
minor FI difference from pure DNA with ETBr, we could infer that the interaction of 
Thim with DNA is weaker than of the complex. 
 
 
Figure 3.8. Fluorescence intensity of solutions containing the compounds studied 
and DNA with increasing concentrations of ETBr. The labels are: black: EtBr only; 
red: EtBr + CT–DNA; blue: thim; green: [CuCl2(thim)2]. Solid line: molar ratio 
(compound/DNA) of 0.1. Dotted line: molar ratio of 0.2. 
  
3.3.7. Circular Dichroism (CD) of DNA 
 
 CD spectroscopy is a useful technique for evaluating DNA secondary structure 
and the changes in its conformation due to interaction with other molecules. 
According to the literature, the CD spectrum of DNA in B form consists of a negative 
band at 245 nm, due to right-handed helicity, and a positive band at 275 nm (not 
evaluated in our experiments) is related to base stacking.[111,112] In the calf-thymus 
DNA a positive band at 220 nm is also observed.[113]  
 Samples of CT-DNA were incubated with the compounds in 10 mmol·L-1 
NaClO4 aqueous solution at different molar ratios and the resulting spectra are 
shown in Figure 3.9.  
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 Electrostatic and simple groove binding of small molecules to DNA do not 
usually lead to major distortions of the CD spectrum of CT-DNA, whereas 
intercalation leads to stabilization of the B-form of DNA, thus increasing the intensity 
of the helicity (245 nm) and stacking (275 nm) bands.[87,114]  
 
 
Figure 3.9. Circular Dichroism of CT-DNA (100 µM) samples in NaClO4 aqueous 
solution (10 mM) incubated with (a) thim and (b) [CuCl2(thim)2] (Labels are: black 
(DNA only), red (ri = 0.10), blue (ri = 0.20), green (ri = 0.30). 
 
 It was observed that thim did not induce significant changes in the CD 
spectrum of CT-DNA in any molar ratio, so it may interact with DNA in a non-
intercalative way. The Cu(II) complex, however, resulted in significant changes in the 
CD spectra even at low molar ratios. The band at 220 nm showed a significant 
decrease in intensity and bathochromic shifts for both complexes. The intensity of the 
CT-DNA band at 245 nm also decreased with increasing complex concentration, 
which indicates that the complex modify DNA helicity. Since major distortions and 
decreasing on the intensity of the band at 245 nm are observed for both complexes, 
non-covalent interactions can be ruled out for [CuCl2(thim)2]. 
Isodichroic points are observed for the [CuCl2(thim)2] complex around 230 nm, 
which is an indicative of more than one DNA conformation present in solution.[115] 
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This partial loss of B conformation of the DNA molecule may impede ETBr 
intercalation with DNA and lead to its fluorescence decrease, described previously. 
 
3.3.8. Thermal denaturation of DNA 
 
 The thermal denaturation or melting temperature (Tm) of DNA is defined as the 
temperature when half of the total base pairs are unpaired.[116] It is the temperature in 
mid-transition from the folded to the unfolded forms of DNA.[117] This experiment is 
commonly used to study interactions of small molecules to DNA, since an increase in 
Tm indicates preferential binding to the folded form compared to the unfolded 
form.[117] 
 The results of thermal denaturation are shown in Table 3.3. The denaturation 
temperature was determined as the temperature in which the second derivative of the 
obtained curve is zero in the 60-80 oC interval (inflection point of the sigmoidal 
curve). 
 
Table 3.3. Denaturation temperatures of DNA for free DNA, thim, [CuCl2(thim)2] and 
Pd-Thim. 
Compounds Results Δ(comp – DNA) 
DNA 67.9 ± 0.9 0.0 
thim 65.8 ± 0.7 -2.1 
[CuCl2(thim)2] 68.5 ± 0.4 0.6 
 
 When a compound intercalates with DNA a high increase (between 8 to 13 °C) 
in Tm occurs.
[116,118] Since only minor changes in Tm are observed for the tested 
compounds an intercalation mode of action is not probable to exist, as it was already 
seen in UV-Vis and CD studies previously discussed. In Table 3.3, it can be seen that 
thim promotes a stabilization of the unfolded form of DNA, as it decreases its Tm by 
approximately 2.1 °C.  
It is known that imidazoles can interact with DNA nucleobases through 
hydrogen bonds.[119,120] It was shown by CD that thim interaction with DNA is not 
sufficiently strong to change conformation of DNA. CD and UV-Vis analysis showed 
that this compound does not intercalate. So, we propose that thim is binding to DNA 
through hydrogen bonds, causing the observed effect on Tm and partially impedes 
the intercalation of ETBr to DNA. 
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 Table 3.3 also shows that the Tm for DNA incubated with [CuCl2(thim)2] did not 
change, since the observed result is within the error. The previous CD analysis 
shows that [CuCl2(thim)2] does not interact with DNA via non-covalent interactions. 
Long-range stabilization of the unfolded form can be compensated by local 
destabilization at sites of interstrand crosslinks.[121] [CuCl2(thim)2] may then be 
binding to DNA via covalent bonds with no preferential mode between intrastrand and 
interstrand. 
 
3.3.9. Antifungal activity assay 
  
 The disc diffusion method was used to evaluate the possible antifungal activity 
of [CuCl2(thim)2]. This compound was found to be active over the Trichophyton 
mentagrophytes strain, with an inhibition zone of 0.6 cm, which is smaller than the 
control compound amphotericin, which showed an inhibition zone of 2.6 cm. 
However, [CuCl2(thim)2] was found to be inactive over Fusarium moniliforme and 
Candida albicans. T. mentagrophytes is one of the major organisms involved in 
dermathophytosis, the infection of keratinized tissues in humans and other 
animals.[122] The free ligand thim was inactive over all three tested fungi, which 
highlights the effect of complexation on the biological properties of the molecule.  
 
3.4. Partial conclusions 
 
 A novel Cu(II) complex with thim was synthesized and fully characterized. 
Elemental and mass spectrometric measurements showed that the complex has the 
composition 1:2:2 metal/ligand/chloride. The structure of [CuCl2(thim)2] was solved by 
single crystal XRD. The complex showed the coordination of thim to the metal ions by 
the imine nitrogen of the imidazole group in a trans geometry, with an increase in the 
torsion angle between the rings. The DNA interaction of thim and [CuCl2(thim)2] was 
evaluated by different techniques. The biophysics studies indicate that thim interacts 
mainly via hydrogen bonding with CT-DNA, while the Cu(II) complex may form 
covalent bonds with CT-DNA, which is consistent due to the presence of coordinating 
atoms from the nucleobases, especially nitrogen. However, the ability of this complex 
to induce DNA cleavage in the absence and in the presence of a reducing agent was 
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not evaluated. Moreover, [CuCl2(thim)2] showed antifungal activity over Trichophyton 
mentagrophytes, but with an inhibition zone much lower than the control 
amphotericin. 
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Chapter 4 
 
 
Synthesis, characterization and preliminary antimicrobial 
assays of copper(II) complexes with 2-(imidazole-2-
yl)heteroaryl ligands  
 
 
The content of this chapter is an adaptation of an article in preparation entitled 
“Synthesis, characterization and preliminary antimicrobial assays of copper(II) 
complexes with 2-(imidazole-2-yl)heteroaryl ligands”. 
 
The introduction of this chapter was not included since it is an adaption of the 
content already presented in Chapter 1. My contribution to this work was in the 
syntheses and characterization of the copper(II) complexes and partial writing of the 
publication.  
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4.1. Experimental Section 
 
4.1.1. Materials and Methods 
 
2-Pyridinecarbonitrile (99%), 2-pyrazinecarbonitrile (99%), 2-
pyrimidinecarbonitrile (97%), aminoacetaldehyde dimethyl acetal 99 % were 
purchased from Sigma Aldrich. CuCl2·2H2O (99%) was purchased from Vetec – 
Sigma (Brazil). Metallic sodium was purchased from Riedel-de Haen. All other 
reagents and solvents were used as received, without further purification.  
Elemental analyses were performed on a Perkin Elmer 2400 CHNS/O 
Analyzer. Conductivity measurements were performed using a LAB1000 conductivity 
meter. The solutions were prepared in deionized water, with concentrations of 1.10-3 
mol·L-1. 
Electronic spectra in the 190-1100 nm range were acquired by using a 1.0 cm 
quartz cuvette in a diode array HP8453 UV/Visible absorption spectrophotometer. 
 Infrared spectroscopy measurements were performed on an Agilent Cary 630 
FTIR spectrometer, using the Attenuated Total Reflectance (ATR) method, with a 
diamond cell. Spectra were recorded from 4000-400 cm-1, with 64 scans and 
resolution of 4 cm-1. Raman spectra were recorded using a Jobin-Yvon T64000 
single spectrometer system, equipped with a confocal microscope and a nitrogen-
cooled change coupled device (CCD) detector. The spectra were collected using a 
632 nm (2 mW) laser at room temperature and with solid samples.  
The 1H NMR spectra of the ligands were recorded in DMSO-d6, in a Bruker 
Avance III 500 MHz (11.7 T) spectrometer.  
Electrospray ionization quadrupole time-of-flight mass spectrometric (ESI-
QTOF-MS) measurements were carried out in a Waters Xevo Q-TOF instrument. The 
samples were analyzed in a 1:1 methanol:water solution with addition of 0.10% (v/v) 
formic acid. Each solution was directly infused into the instrument’s ESI source and 
analysed in the positive mode, with capillary potential of 3.00 kV, source temperature 
of 120 oC and nitrogen gas for desolvation.  
X-Ray Powder Diffraction analyses were performed with a Shimadzu 
XRD7000 diffractometer, with a copper tube operating at 40 kV and 30 mA. The 
divergence and scatter slits were of 1.0o and the receiving slit was of 0.30 mm. The 
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scanning was performed in the continuous mode, from 5 to 50o and scan speed of 
2o·min-1. Data collection for [CuCl2(impm)] single crystals was performed with a 
Bruker Apex II CCD diffractometer with graphite monochromated Mo - Kα ( = 
0.71703 Å) radiation. More information about refinement and data treatment can be 
found in Chapter 2 – subitem 2.2.3. 
Molecular modeling calculations were performed according to details 
presented in Chapter 3 – subitem 3.2.3.  
 
4.1.2. Syntheses of the ligands 
 
The ligands were synthesized in accordance to a reported method for the 
preparation of 2-substituted imidazoles.[59]  
 
2-(Imidazol-2-yl)pyridine (impy) 2.60 g (25 mmol) of 2-pyridinecarbonitrile, 10 mL 
MeOH and 0.47 mL (2.5 mmol) of a 30 % solution of NaOMe in MeOH were added to 
a 100 mL round-bottom flask,. The mixture was stirred for 1 hour at 40 °C. 2.72 mL 
(25 mmol) of aminoacetaldehyde dimethyl acetal, followed by 2.75 mL of AcOH were 
added dropwise to the mixture and heated under reflux for 30 min. After the mixture 
was left to cool at room temperature, 15 mL of MeOH and 12.5 mL of HCl 6 mol·L−1 
were added and the reaction was heated under reflux for 4.5 h. After that, the 
solution was evaporated to dryness and 27.5 a freshly prepared warm 1 g·mL−1 
solution of K2CO3 was added dropwise, to adjust the pH to 10. This resulted in a 
reddish suspension that, after cooled to room temperature, was filtered and the 
filtrate was extracted with 50 mL of CH2Cl2. The resulting red solution was 
evaporated to dryness and recrystallized in boiling ethyl acetate. The product was 
obtained as a dark yellow powder, which was dried under vacuum. Yield 60 %. Anal. 
Calc. for C8H7N3 (%): C 66.19; H 4.86; N 28.95. Found: C 65.58; H 5.06; N 28.48. 
1H 
NMR (500 MHz, DMSO-d6): δ 7.160 (s, 2H), 7.362 (ddd, 1H, J = 1.0, 5.0, 7.5 Hz), 
7.888 (td, 1H, J = 1.5, 7.8 Hz), 8.044 (dt, 1H, J = 1.0, 8.0 Hz), 8.602 (ddd, 1H, J = 
1.0, 1.5, 4.5 Hz), 12.770 (br) (for the spectrum, see Figure C.1). HRMS (ESI-(+)-
TOF) (m/z): calcd for C8N3H8 [M+H
+]+: 146.07, found: 146.07.  
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2-(Imidazol-2-yl)pyrazine (impz) Experimental details for this molecule were 
reported in Chapter 2 – subitem 2.2.2.  
 
2-(Imidazol-2-yl)pyrimidine (impm) To a 100 mL flask were added 2.62 g (25 
mmol) of 2-pyrimidinecarbonitrile, 10 mL of MeOH and 0.47 mL of a 30 % solution of 
NaOMe in MeOH. The mixture was kept under vigorous stirring at room temperature 
for 1.5 hour. Then, 1.63 mL (15 mmol) of aminoacetaldehyde dimethyl acetal was 
added, followed by dropwise addition of 2.75 mL of AcOH. The system was heated 
under reflux for 30 minutes. After cooling, 15 mL of MeOH and 12.5 mL of HCl 6 
mol·L−1 were added and the system was heated under reflux for 5 hours. After the 
reaction time, the solvent was rotary evaporated and 27.5 mL of a warm K2CO3 1 
g·mL−1 solution were carefully added, forming a yellowish suspension which after 
cooling, was filtrated in a Buchner funnel. This ligand was obtained as a pale yellow 
powder. Yield 68 %. Anal. Calc. for C7H6N4 (%): C 57.53; H 4.14; N 38.34. Found: C 
57.52; H 4.20; N 39.06. 1H NMR (500 MHz, DMSO-d6): δ 7.234 (s, 2H), 7.442 (t, 1H, 
J = 5.0 Hz), 8.875 (d, 2H, J = 5.0 Hz), 12.972 (br) (for the spectrum see Figure C.2). 
HRMS (ESI-(+)-TOF) (m/z): calcd for C7N4H7 [M+H
+]+: 147.07, found: 147.06.  
 
4.1.3. Syntheses of the Cu(II) complexes 
 
The three complexes were synthesized by the mixture of methanolic solutions 
of the ligands and methanolic solution of CuCl2·2H2O, with 1:1 stoichiometry 
(metal:ligand), under stirring and at room temperature for four hours.  
 
[CuCl2(impy)] Starting solutions: 1.0 mmol in 10 mL. A light-green solid precipitated 
and the powder was collected by filtration, washed with a small amount of cold 
methanol and dried under vacuum. The yield was 52%. This complex is soluble in 
water and DMSO and slightly soluble in methanol and ethanol. Anal. Calc. for 
CuCl2C8H7N3 (%): C 34.36; H 2.52; N 15.02. Found: C 34.49; H 2.75; N 14.97. Molar 
conductivity in deionized water (S·cm2·mol-1): 203.7. 
 
[CuCl2(impz)] Starting solutions: 0.5 mmol in 5 mL. A green solid precipitated and 
the powder was collected by filtration, washed with a small amount of cold methanol 
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and dried under vacuum. The yield was 38%. This complex is soluble in water, 
DMSO and DMF and slightly soluble in methanol and ethanol. Anal. Calc. for 
CuCl2C7H6N4 (%): C 29.96; H 2.16; N 19.97. Found: C 30.24; H 2.46; N 19.78. Molar 
conductivity in deionized water (S·cm2·mol-1): 206.9. 
 
[CuCl2(impm)] Starting solutions: 0.5 mmol in 5 mL. After four hours of stirring, no 
precipitation occurred. The solution was rotaevaporated to dryness and the remaining 
green solid was thoroughly washed with cold ethanol and dried under vacuum. The 
yield was 33 %. This complex is soluble in water, methanol, DMSO and DMF. Anal. 
Calc. for CuCl2C7H6N4 (%): C 29.96; H 2.16; N 19.97. Found: C 29.58; H 2.32; N 
19.66. Molar conductivity in deionized water (S·cm2·mol-1): 288.2. Single crystals of 
Cuimpm were obtained after slow concentration of a methanolic solution of this 
complex.  
 
4.1.4. Antimicrobial assays  
 
The Minimal Inhibitory Concentration (MIC) of impy, impz and impm and their 
corresponding Cu(II) complexes was evaluated over the Gram-positive S. aureus 
(ATCC 25923) and the Gram-negative E. coli (ATCC 25922) bacterial strains, 
according to standard procedures.[123]  
The stock solutions of the ligands were prepared in DMSO and of the 
complexes in water. The strains were inoculated in tubes containing 2.0 mL of Brain 
Heart Infusion (BHI) and incubated for 18 hours at 35-37 oC. Sufficient inoculum of 
each bacterial suspension was added to new tubes of sterile BHI up to the value of 
1.0 turbidity on the McFarland nephelometric scale (~ 3.0 x 108 CFU·mL-1). 100 µL of 
the samples (stock solutions of concentration 20 µg·µL-1) were added to different 
wells of a 96 well multiplate. Afterwards, 100 µL of the bacterial suspensions were 
added to serial dilution, up to a 0.5 McFarland nephelometric scale (~ 3.0 x 108 
CFU·mL-1) and a final volume of 200 µL·well-1. The microplates were incubated for 18 
h at 35-37 oC. After the incubation time, 15 µL of a 0.01 % resazurin solution (in 
sterile water) were added to each well. After 4 hours of reincubation, the 
measurement was performed. These experiments were performed in collaboration 
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with Professor Dr. Wilton Rogério Lustri and his research group (QUIMMERA) from 
UNIARA. 
 Antifungal activity assays were performed as reported in Chapter 3, subitem 
3.2.9.  
 
4.2. Results and discussion 
 
4.2.1. Synthesis  
 
The ligands were synthesized according to a procedure[59] for the preparation 
of 2-substituted imidazoles and the characterization results are consistent with the 
reported data. Elemental analyses of the prepared copper(II) compounds matched 
the proposed composition of one copper, one 2-(Imidazol-2-yl)heteroaryl ligand and 
two chlorides, resulting in a net zero charge for the complexes.  
 However, conductivity measurements of the Cu(II) compounds in deionized 
water (values reported in Experimental Section) showed that they behave as 1:2 
electrolytes[124,125], so the chlorides are readily hydrolyzed in aqueous solution, and 
possibly lead to the formation of a charged [Cu(OH2)2(impx)]
2+ (x = y, z or m) 
complex. This is consistent with the behavior of the analogous copper complex with 
bipyridine in water.[126]  
 Mass spectrometry results showed the [Cu(II)Cl(impx)]+ ion for all complexes 
and the [Cu(I)(impx)]+ ion resultant from the loss of the second chloride and 
concomitant copper reduction, though no adducts with water were easily identified. 
Copper(II) reduction is a common process in mass spectrometry experiments.[103] 
The mass spectra of all complexes are given in Appendix C (Figures C.3 to C.5). 
 
4.2.2. X-ray diffraction 
 
 The crystalline structure of [CuCl2(impy)] has already been solved in the 
literature[61] by X-Ray Powder Diffraction and refined using Rietveld analysis and the 
assymetric unit of this compound is given in Figure 4.1 (a). The pattern from the 
synthesized [CuCl2(impy)] (Appendix C, Figure C.6) is in agreement with the one 
already reported, thus indicating that the samples have similar structures. Each 
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copper center interacts axially with a chloride from an adjacent molecule with length 
that may be considered a weak bond, characteristic of Jahn-Teller distortions for the 
Cu(II) electronic configuration.[22] 
 Even though several attempts of obtaining single crystals from [CuCl2(impz)] 
did not yield any suitable for diffraction, its powder diffractogram was recorded and is 
shown with the one recorded from impz in Appendix C, Figure C.5. [CuCl2(impz)] has 
a low cristallinity profile, while the corresponding ligand impz is much more 
crystalline, as proved by the greater signal intensity (the data were normalized for 
better comparison) and shorter peak width. It is hypothesized that the three 
complexes may adopt similar structures and this is supported from their chemical 
similarity ,as seen from the data of other characterization techniques. 
 Single crystals of [CuCl2(impm)] suitable for diffraction were obtained after 
slow evaporation of a methanolic solution. This molecule crystallized in the 
orthorrhombic crystal system, space group P212121. The copper ion is coordinated to 
nitrogen atoms from the pyrimidine and imidazole rings and to two chlorides. The 
calculated η4 geometry index
[127] for this complex was 0.09, which indicates a slightly 
distorted square planar geometry, as seen in Figure 4.1 (b). The angle between the 
planes of the imidazole and pyrimidine rings show that they are almost coplanar in 
this complex (angle = 1.27(15)o). Crystallographic information of [CuCl2(impm)] can 
be found in Table 4.1. 
When comparing the bond lengths reported for [CuCl2(impy)]
[61] to the values 
in [CuCl2(impm)], the Cu-Nimid values are of the same magnitude (1.951(5) Å and 
1.975(5) Å, respectively). The Cu-Npyridine bond length (2.117(5) Å) is longer than 
Cu-Npyrimidine (2.078(2) Å). However, both Cu-N bond lengths are within the average 
values found in CSD[74] for Cu-N (1.970(17)) Å in imidazole moieties and 2.061(50) Å 
for pyrimidine moieties) in tetracoordinated copper(II) complexes. The Cu-Cl1 and 
Cu-Cl2 bond lengths are 2.2489(6) and 2.2425(6) Å, respectively. These values are 
also in agreement with those found in the CSD (2.242(31) Å) for the average Cu-Cl 
distance in a tetracoordinate environment.  
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Table 4.1. Crystallographic data of [CuCl2(impm)] structure. 
Empirical formula C7H6Cl2CuN4 
Coordination formula [CuCl2(C7H6N4)] 
Molecular weight (g·mol-1) 280.61 
Temperature (K) 296 
Wavelength (Å) Mo - Kα 0.71073 
Crystal system Orthorrhombic 
Space Group P212121 
a (Å) 6.3102(6) 
b (Å) 8.5236(8) 
c (Å) 17.3125(17) 
α (o) 90 
β (o) 90 
γ (o) 90 
V (Å-3) 931.16(15) 
Z 4 
ρcalcd. (g cm
-3) 2.002 
F(000) 556 
μ (mm-1) 2.878 
θ range (o) 2.664 – 30.508 
Reflections collected/ independent 13620/ 2607 (Rint= 0.0280) 
Data/ restraints/ parameters 2607/ 0/ 137 
R1,wR2 [I > 2σ (I)] 0.0203, 0.0457 
Diff. peak and hole (e/Å-3) 0.39 and -0.28 
Goodness-of-fit on F2 1.037 
CCDC number 1441825 
 
 
Figure 4.1. Comparison of the structures of (a) [CuCl2(impy)] and (b) [CuCl2(impm)]. 
[CuCl2(impy)] was adapted from the CIF from reference [61] and represented by full 
circles due to powder diffraction measurements. Atomic displacement ellipsoids of 
[CuCl2(impm)] are at the 50% probability level. Hydrogen atoms are represented by 
white spheres. 
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 In the crystal structure of [CuCl2(impm)], there is no significant axial bonding 
nor interaction of a copper center to chlorides from adjacent molecules (see Figure 
4.2 (b)), though they do superimpose. The measured values of the hypothetic 
interactions of a copper center with chlorides located directly above and below it 
[Cu1···Cl2i (i = ±1/2 + x, 3/2 - y, -z)] are 3.1587(10) and 3.1822(10) Å, respectively. In 
many Cu(II) structures there are some minor axial interactions, but the geometry 
around the copper center can be considered square planar if the axial distances are 
greater than 3.0 Å.[22] As mentioned before, [CuCl2(impy)] shows a Cu-Cl axial 
interaction (Figure 4.2 (a)), with value 2.847(5) Å[61], thus showing the difference in 
packing between the two complexes. 
 
 
Figure 4.2. Representations of (a) Cu–Cl···Cu in [CuCl2(impy)] and (b) Cu···Cl···Cu 
in [CuCl2(impm)]. [CuCl2(impy)] was adapted from the CIF from reference [61]. 
 
Short[77] hydrogen bonds connect the [CuCl2(impm)] molecules, forming an 
infinite 2D chain motif through N2-H2···Cl2ii [H···A 2.32 Å, A···D 3.1710(18) Å, < 
(DHA) 169.3˚ (ii = x, -1 + y, z)]. A weaker interaction[78] involves C3-H3···Cl1iii [H···A 
2.87 Å, A···D 3.444(2) Å, < (DHA) 120.9˚ (iii = 1 - x, -1/2 + y, -1/2 - z)] (Figure 4.3). 
π···π offset interactions contribute to the stacking of [CuCl2(impm)] molecules and the 
centroid···centroid average distance is of 3.6 Å, which is within the values usually 
found for N-heterocycles (3.3. to 3.8 Å).[69]  
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Figure 4.3. Molecular interactions in [CuCl2(impm)].  
 
4.2.3. Molecular modeling 
 
Since the structure of [CuCl2(impz)] was not solved by diffraction, molecular 
modeling was performed to obtain information about this compound. The equilibrium 
geometry of [CuCl2(impz)] is shown in Figure 4.4, along with its frontier Kohn-Sham 
orbitals.  
It can be seen that in the equilibrium geometry, this complex adopts the same 
coordination as [CuCl2(impy)] and [CuCl2(impm)], with bonding of Cu(II) to the 
nitrogens of the pyrazine and imidazole rings and to two chlorides, in a square planar 
geometry. The values of important bond lengths and angles of [CuCl2(impz)] can be 
found in Table 4.2. No major differences are found between the calculated values for 
the three different complexes, which is consistent with their similarity in chemical 
composition and geometry. 
The SOMO (α orbital) of [CuCl2(impz)] has a contribution of the 3dx
2-y
2 metal 
orbital, as expected for a d9 configuration in a square planar geometry. The LUMO (α 
and β) consist mainly of the π* system of the impz ligand, with a contribution from 
Cu(II).  
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Figure 4.4. Equilibrium geometry and frontier Kohn-Sham orbitals obtained for 
[CuCl2(impz)] by DFT calculations with PBE0/def2-TZVP. 
 
The optimized geometries of [CuCl2(impy)] and [CuCl2(impm)] (see Appendix 
C, Figures C.8 and C.9, respectively) are in agreement with those found 
experimentally, as shown in the bond lengths and angles values from Table 4.2. The 
main deviations are the overestimations of Cu-N bond lengths and the Cl-Cu-Cl bond 
angle. The latter can be explained because of the existence of hydrogen bonding 
involving the chloride ions in the solid state, which are not taken into account in the 
calculations.  
The Kohn-Sham orbitals for these compounds (Figures C.8 and C.9) show 
some differences which highlight the effect of increasing the number of nitrogen 
atoms (or changing its position) on the electronic structure of the complexes. This 
can be seen from the frontier orbitals of either [CuCl2(impm)] or [CuCl2(impz)] 
compared to [CuCl2(impy)]. The first two complexes have an extra nitrogen atom 
which shows contribution for the frontier orbitals, as opposite to the corresponding 
carbon atom in [CuCl2(impy)]. 
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Table 4.2. Optimized bond lengths and angles of the copper(II) complexes. 
Bond length (Å) or 
angle (o) 
[CuCl2(impy)] 
(experimental)* 
[CuCl2(impz)] [CuCl2(impm)] 
(experimental) 
Cu-Nimid 2.036 (1.951(5)) 2.036 2.042 (1.9750(17)) 
Cu-Npyr** 2.199 (2.119(5)) 2.222 2.216 (2.0779(16)) 
Cu-Clt, imid*** 2.197 (2.195(5)) 2.191 2.196 (2.2425(6)) 
Cu-Clt, pyr 2.220 (2.255(5)) 2.214 2.212 (2.2489(7)) 
N-Cu-N 76.10 (78.72(19)) 75.66 76.18 (80.48(7)) 
Cl-Cu-Cl 100.97 (92.70(18)) 101.74 101.93 (94.67(2)) 
* from reference 
[61]
 
** pyr = pyridine, pyrazine or pyrimidine 
*** Cl trans to imidazole ring 
 
4.2.4. Vibrational spectroscopies 
 
The full experimental and theoretical FTIR spectra of the compounds are 
shown in Appendix C, Figures C.10 and C.11. The N-H and C-H stretchings[128] were 
expected to not differ much in energy when comparing the complexes, as these do 
not change much in structure to alter these vibrations. The calculated values for 
these stretchings are very similar and above 3000 cm-1. The experimental band 
pattern next to the 3000 cm-1 region is also quite similar for all complexes, as 
expected.  
The region from 1700 to 1200 cm-1 shown in Figure 4.5, however, is quite 
distinct for the complexes. From 1600 to 1400 cm-1, combinations of C-Caromatic and 
C-Naromatic vibrations from the rings are observed
[128], which justifies the differences in 
the spectra, as the six-membered N-heterocyle change in each complex.  
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Figure 4.5. Partial ATR Infrared spectra of the copper(II) complexes. 
 
Notably the bands observed at 1468, 1454 and 1459 cm-1, for [CuCl2(impy)], 
[CuCl2(impz)] and [CuCl2(impm)], respectively, follow the trend of pKa values 
(defined from the equilibrium between the protonated and deprotonated N-
heterocycles) of the free six-membered N-heterocycles (5.23, 0.65 and 1.21 for 
pyridine, pyrazine and pyrimidine, respectively)[129]. Results from molecular modelling 
showed that these vibrations have a component of streching of the C-N-Caromatic 
group (from the six-membered ring) involved in coordination to copper(II) and 
components from imidazole vibrations as well. An attempt to rationalize this energy 
order is indirectly relate it to the strength of the Cu-N bond. A stronger bond to Cu(II) 
(as in [CuCl2(impy)]) would hamper the C-N-Caromatic stretching energy, thus leading 
to an increase of the energy required for such vibration to occur. 
In order to investigate metal-ligand vibrations, the Raman spectra of the solid 
complexes were recorded from 100 to 600 cm-1 and are shown in Figure 4.6. 
The attribution of copper-N and copper-Cl vibrations in imidazole[130], 
bipyridine and phenantroline[131,132] complexes has been studied in the past. 
However, exact attribution of the bands is misleading, as both vibrations tend to fall 
within the 200 – 300 cm-1 region, as opposite to Cu-N from exclusive ζ donors, as 
ammonia and ethylenediamine[133], which fall well-above 300 cm-1.  
In the [CuCl2(bipy)] complex
[131], two infrared bands were attributed to Cu-Cl 
stretching vibrations at 259 and 304 cm-1 and one band was assigned as Cu-N at 292 
cm-1. For the corresponding [CuCl2(phen)] complex, the Cu-Cl stretching was 
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assigned to two bands at 281 (shoulder) and 288, while Cu-N was assigned at 313 
cm-1. These attributions were made by comparing similar complexes with varying 
counterions.[131] Similarly, a [CuCl2(imidazole)2] complex (polymeric, Oh symmetry) 
also showed two bands assigned to Cu-Cl at 276 and 245 cm-1 and one Cu-N at 306 
cm-1. The attributions in this paper were made by studying isotope substitution (63Cu 
and 65Cu).[130] 
 
 
Figure 4.6. Raman spectra of the [CuCl2(impx)] complexes. Values reported in cm
-1. 
 
The infrared calculations performed in this work predicted that there should be 
two bands with a component of Cu-Cl stretching around 320 cm-1 for the bond trans 
to the six-membered ring and 345 cm-1 for Cu-Cl trans to the imidazole ring. Even 
though the intensity of these calculated (infrared) transitions cannot be directly 
compared to those observed in the Raman spectrum from Figure 4.6, the presence of 
bands within 250 and 350 cm-1 are strong evidences of Cu-Cl stretchings in all three 
molecules. An attempt of band assignment, along with calculated infrared values are 
given in Table 4.3. 
Contrary to what was reported for Cu-N stretchings, calculations showed that 
these vibrations should occur at 140 cm-1 for the Cu-Npyr (pyr = pyridine, pyrazine and 
pyrimidine) bond and 180 cm-1 for the bond to imidazole. These data suggest that the 
bond strength is greater for imidazole than for the six-membered rings, but there was 
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no significant difference (see Table 4.3) in bond strength between the pyridine, 
pyrazine and pyrimidine rings. Calculations of Raman spectra would allow more 
direct comparison and are under progress. 
 
Table 4.3. Cu-L stretching vibrations in [CuCl2(impx)] complexes. 
Stretching 
vibration (cm-1) 
[CuCl2(impy)] 
(calculated) 
[CuCl2(impz)] 
(calculated) 
[CuCl2(impm)] 
(calculated) 
υ Cu-Nimid 171 (184) 168 (183) 176 (180) 
υ Cu-Npyr* 132 (142) 132 (139) 131 (136) 
υ Cu-Clt, imid** 318 (343) 303 (347) 298 (343) 
υ Cu-Clt, pyr 294 (319) 270 (321) 283 (322) 
* pyr = pyridine, pyrazine or pyrimidine 
** Cl trans to imidazole ring 
 
It must be highlighted that the three spectra have similar patterns, which is a 
spectroscopic evidence that supports the hypothesis these compounds do adopt 
similar geometries in the solid state. The axial Cu-Cl bond present in [CuCl2(impy)] 
(as discussed in diffraction section) and the fact that it is the complex with only one 
nitrogen atom in the six-membered ring may be the reasons of the observed 
differences.  
 
4.2.5. Electronic spectroscopy  
 
 Electronic spectra of the concentrated copper(II) complexes solutions were 
recorded in order to observe d-d transitions of low absorptivity (Figure 4.7 and Table 
4.4), whereas diluted solutions were studied to obtain insights on the intraligand 
transitions (Figure 4.8). It must be highlighted, however, that, as seen from 
conductivity measurements, the structures determined by crystallography are not 
maintained in aqueous solutions, as the chlorides are readily hydrolized. In order to 
maintain a high chloride concentration, the spectra were recorded in aqueous KCl 0.1 
mol·L-1. 
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Figure 4.7. Electronic spectra of concentrated [CuCl2(impx)] complexes solutions in 
aqueous KCl 0.1 mol·L-1. 
 
 Figure 4.7 shows that all complexes had d-d transitions with absorption 
maxima blue-shifted in comparison to CuCl2·2H2O (λmax = 820 nm), which is 
consistent with the stronger fields induced by the imidazolic ligands. The molar 
absorptivity coefficients of such d-d transitions were only estimated because of the 
baseline not being zero at these concentrations due to light scattering by partially 
undissolved complex particles.  
 The order of band maxima observed in the spectra is [CuCl2(impz)] < 
[CuCl2(impy)] < [CuCl2(impm)]. The difference of this observed order from what was 
expected from the pKa values of the corresponding six-membered N-heterocycles 
(5.23, 0.65 and 1.21 for pyridine, pyrazine and pyrimidine, respectively)[129] is 
[CuCl2(impz)], which should give the lowest blue-shift assuming ζ-donation is the 
major effect from the heterocycles. 
The ligand impy shows two bands above 250 nm and one more at higher 
energies (below 220 nm). Upon Cu(II) coordination, the band at 292 nm undergoes a 
batochromic shift up to 308 nm. The absorption coefficients, which are related to 
transition probabilities, were not altered much. 
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Table 4.4. Wavelength maxima and molar absorption coefficients of electronic 
transitions of impx ligands and [CuCl2(impx)] complexes in KCl 0.1 mol·L
-1. λ given in 
nm; ε given in L·mol-1·cm-1. 
Compound λ1/ ε  λ2/ ε  λ3/ ε  λ4/ ε  d-d/ ε  
impy - 263 
(6.9.103) 
- 292 
(10.4.103) 
- 
[CuCl2(impy)] - 262 
(6.9.103) 
- 308 
(10.9.103) 
727 (32) 
impz 230 
(5.4.103) 
273 
(10.2.103) 
296 
(11.1.103) 
319 
(12.8.103) 
- 
[CuCl2(impz)] 231 
(6.1.103) 
269 
(8.1.103) 
- 329 
(8.4.103) 
707 (46) 
impm - 284 
(10.1.103) 
- - - 
[CuCl2(impm)] - 283 
(9.6.103) 
- 303 (sh) 
(8.7.103) 
731 (21) 
 
 The ligand impz shows a more complex spectrum than impy, consisting of at 
least four bands. The addition of one nitrogen atom on the pyridine ring at position 4 
(pyrazine) led to changes on the electronic properties of the ligand. The least 
energetic band of impz at 319 nm underwent the same batochromic shift observed 
for [CuCl2(impy)], but of 10 nm. The observed band at 296 nm seen in impz is 
identified as a shoulder next to the band 269 nm in [CuCl2(impz)]. This complex is the 
one that showed greatest differences between its spectrum and of the ligand, even in 
absorption coefficients. This indicates that coordination greatly affects the electronic 
properties of impz. 
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Figure 4.8. Electronic spectra of diluted impx ligands and [CuCl2(impx)] complexes 
solutions in aqueous KCl 0.1 mol·L-1. The spectra were normalized for better 
comparison. 
  
 By changing the position of the nitrogen atom on the heteroaryl ring from 4 
(pyrazine) to 3 (pyrimidine), the spectrum of the corresponding pyrimidine ligand 
appears to be simpler. However, this single broad band became wider after 
coordination, which indicates it is actually a superposition of several electronic 
transitions. This was proved by the spectrum of [CuCl2(impm)], which is even broader 
and a new transition can be identified as a shoulder at 303 nm. The trend of 
batochromic shift of the band observed for the other molecules was also seen for this 
complex.  
 The red shift observed for all complexes is an evidence of complexation and 
that the nature of this transition is the same for these molecules. However, identifying 
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the exact origin of batochromism is difficult, as coordination may influentiate the 
energies of the orbitals of the ground state, excited state or both at the same time.  
 
4.2.6. Antimicrobial activity assays 
 
The MIC values of the compounds over Gram-negative (E. coli) and Gram-
positive (S. aureus) bacterial strains are shown in Table 4.5. It was found that both 
strains were resistant to all ligands. The copper complexes, however, showed activity 
over both strains, with values similar to CuCl2·2H2O, which is known for its 
antibacterial and antifungal activities, though at high concentrations.[16] The close 
values to CuCl2·2H2O and no distinction between the MIC for the complexes may be 
an evidence that labilization of the impx ligands occurs in the tested conditions, even 
though mass spectrometry and electronic spectroscopy did not indicate this loss in 
diluted concentrations. The similar activity profile may also be due to the charge of 
the aquo species formed in solution (as observed from conductivity measurements), 
which may hamper cell uptake, which is a key step[16] in copper(II) activity, unless 
there is a membrane damage mechanism.  
 
Table 4.5. MIC values of the Cu(II) complexes, in comparison to CuCl2·2H2O. 
Samples S. aureus 
(MIC - µmol·mL-1) 
E. coli 
(MIC - µmol·mL-1) 
CuCl2 ·2H2O 14.7 14.7 
[CuCl2(impy)] 17.8 17.8 
[CuCl2(impm)] 17.8 17.8 
[CuCl2(impz)] 17.8 17.8 
 
The disc diffusion method of evaluating antifungal activity showed that the 
ligands and the complexes were not active over Fusarium moniliforme, Candida 
albicans and Trichophyton mentagrophytes under the tested conditions. 
 
4.3. Partial conclusions 
 
Two new Cu(II) complexes with the impz and impm ligands, of composition 
[CuCl2(impx)] were synthesized and had their properties compared to the already 
reported complex with impy. The crystal structure of [CuCl2(impm)] was solved by 
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single crystal XRD, which showed a slightly distorted square planar geometry, with 
no axial bonding to another chloride, as opposed to the reported [CuCl2(impy)] 
structure. Molecular modeling and spectroscopic techniques indicated that the 
[CuCl2(impz)] complex, which did not have its structure solved by diffraction, adopts a 
similar geometry to the other two compounds. The complexes showed antibacterial 
activity over E. coli and S. aureus, with MIC values similar to CuCl2·2H2O, but 
showed no antifungal activity over the three tested strains under the tested 
conditions.  
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Chapter 5  
 
 
Global discussion and conclusions 
 
 
 Several N-heterocycles containing either imidazole or tetrazole rings in their 
structures have been synthesized and characterized. Chapter 2 of this dissertation 
discusses about the crystal structure of some of the N-heterocyclic ligands of interest 
in our research group.  
An important feature from the chemistry of imidazoles and tetrazoles is the 
proton tautomeric equilibrium[134] in solution between the amino and imino nitrogens, 
which could be verified by 1H NMR spectroscopy (see the spectra in Appendices A to 
C)  
The 1H NMR spectra of impz (Appendix A) and thim (Appendix B) showed two 
broad separate signals from the hydrogens bound to the two carbon atoms from the 
imidazole ring. The spectra of impy and impm (Appendix C), however show only one 
broad signal with integration to two hydrogens. The proton equilibrium is facilitated in 
a protic solvent, such as water itself. Possibly, the water content present in the 
samples, the glassware or in DMSO – d6 contributed to the equilibrium in impy and 
impm, though sample preparation was the same for all ligands. 
 The crystallographic data from the tetrazolic ligand tzpy showed the presence 
of a zwitterion (pyridinium and tetrazolate ions) in the solid state, opposite to the 
usually reported neutral molecule. However, solution studies using NMR (appendix 
A) showed that the molecule indeed converts to the neutral form even in the aprotic 
solvent DMSO and thus it adopts the reported form. 
1H NMR was also useful to compare the chemistry of tetrazoles and 
imidazoles. The hydrogen directly bound to the tetrazolic ring is attributed (in the 
literature) to a signal around 3 ppm which is much more shielded than the 
corresponding hydrogen in imidazole (above 12 ppm). Moreover, mass spectrometry 
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experiments indirectly showed differences from chemical stabilities of the two rings 
(Appendix A), as the imidazolic ligands usually lost HCN fragments, whereas the 
tetrazolic ligand tzpy lost N2.  
 The crystal structures from three of the studied ligands showed the importance 
of the hydrogen from imidazole and tetrazole in the determination of the 
supramolecular structure of such molecules. Identification of intermolecular 
interactions of a class of molecules is essential for the rational design of new 
structures in supramolecular chemistry.  
 About the bioactivity of azoles, it is interesting that the tested imidazolic 
ligands were not active over neither bacteria nor fungi. The structure of antifungal 
imidazolic compounds has an N-substituted imidazole.[50] So, from the obtained 
results, substitution of 2-substituted imidazoles with another aromatic ring, such as 
pyridine, does not lead to highly active antimicrobial compounds.  
 Chapters 3 and 4 describe the syntheses and characterization of the copper(II) 
complexes with the imidazolic N-heterocycles, that are different in both geometric 
configurations, mode of binding and number of ligands: [CuCl2(thim)2] adopted trans 
configuration, monodentate coordination via imidazole and the stoichiometry of two 
ligands was set to maintain two nitrogen atoms bound to copper. In the [CuCl2(impx)] 
complexes, the ligands coordinated in a chelate bidentate mode by both the 
imidazole and the six-membered aromatic rings. It is only hypothesized that 
[CuCl2(thim)2] adopted a trans configuration due to steric hindrance that a cis 
configuration would impose in the crystal packing.  
 Comparison of crystallographic data from the trans [CuCl2(thim)2] and the 
[CuCl2(impm)] complexes showed that the former adopted a regular square planar 
geometry (η4 index
[127] zero), whereas the latter was slightly distorted, with the copper 
ion located slightly out of the ligand plane (η4 index 0.09). No significant Cu–Cl axial 
bonding was identified for neither complexes, but hydrogen bonding involving 
chlorides was shown to be essential for crystal packing. The presence of these 
unconventional N-H···Cl hydrogen bonds may be one of the reasons why no solvent 
molecules were necessary for crystallization.  
 The Cu-N bond length for imidazole coordination (1.9750(17) Å) in 
[CuCl2(impm)] was shorter than the one for pyrimidine (2.0779(16) Å) and the same 
trend was observed in the reported [CuCl2(impy)]
[61] structure. Relating bond length to 
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bond strength can be misleading even with crystal data, unless the changes between 
the compared structures are really significant (for example changing the oxidation 
state of the metal). It has been stated that the difference between M-Nimidazole and 
M-Npyridine bond lengths is probably more related to steric effects than to a stronger 
bond.[135] 
Molecular modeling allowed the prediction of the equilibrium geometry of 
[CuCl2(impz)], which did not have its structure solved by diffraction. It could be seen 
from the plotted Kohn – Shan orbitals that the presence of extra number of nitrogen 
atoms affects the electronic structure of the molecule. Molecular modeling did not 
predict any significant differences between the Cu-N (from pyridine, pyrazine and 
pyrimidine) bond lengths.  
 Some chemical differences between the complexes were observed and they 
could be directly related to their mode of coordination. For example, the copper(II) ion 
from the monodentate [CuCl2(thim)2] complex was easily reduced in mass 
spectrometry experiments, resulting in the loss of two chloride ions and only the 
[Cu(I)(thim)2]
+ species was observed. However, for the [CuCl2(impx)] complexes, the 
bidentate coordination of the ligands ensured greater stabilization of copper(II), so 
some [Cu(II)Cl(impx)]+ ions survive in the gas phase, though [Cu(I)(impx)]+ is still the 
dominant species. Chloride solvolysis was also proved by conductivity 
measurements. 
  Infrared spectroscopy, along with molecular modeling, was used to identify 
the vibrations that have contribution of imidazole stretching, which changed after 
coordination to Cu(II). Raman spectroscopy was used to evaluate the metal-ligand 
vibrations. All three complexes had similar spectra profiles, with small differences in 
band energies, which is consistent with a similar mode of coordination.  
 Electronic spectroscopy in solution showed a hypsochromic shift of the d-d 
band of the complexes compared to CuCl2·2H2O, which is an indication of the 
stronger field of the N-heterocycles when compared to water. Moreover, in the 
[CuCl2(impx)] complexes, some of the intraligand electronic transitions showed a 
batochromic shift, which is consistent with coordination. The fact that the intraligand 
bands of thim did not show a shift after coordination to Cu(II) may indicate that they 
are predominantly related to thiophene transitions, which is not involved in 
coordination, as proved by other techniques. 
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 The complexes of the tetrazolic ligands with Cu(II) were not synthesized in this 
work, and studying them would add information about the effects of the five-
membered ring on the properties of the complexes. The versatile nature of the Cu(II) 
ion also allows the obtention of bis and tris complexes with the studied ligands, which 
remain to be investigated. 
The synthesized copper(II) complexes were tested over bacterial and fungal 
strains. The three [CuCl2(impx)] complexes were tested in relation to their 
antibacterial properties and they showed MIC values similar to CuCl2·2H2O over E. 
coli and S. aureus. However, the number and the position of the nitrogen atoms in 
the ligand did not influence the antibacterial activity of the complexes. This profile 
may be related to the dominant effect of high positive charge of the complexes, which 
may hinder their entrance in the cells.[16]  
 [CuCl2(thim)2] was the only compound that showed antifungal activity over 
Trichophyton mentagrophytes. This shows the difference that stoichiometry and trans 
geometry played in the determination of bioactivity, as the [CuCl2(impx)] complexes 
were not active. The presence of thiophene was not the determinant factor of 
antifungal activity of [CuCl2(thim)2], as the free ligand did not show an inhibition zone.  
 Even though the studied molecules in this work showed limited antimicrobial 
activity, the results showed that substitution of classical bipyridine and phenantroline 
by other classes of ligands, such as imidazole, may be promising for further tailoring 
of copper(II) complexes. Chemical modifications of the studied ligands, such as the 
obtention of lipophilic cations and substituting the labile chloride ligands by other 
bioactive ligands may lead to more active compounds. 
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Appendix A 
 
 
Supplements to Chapter 2 
 
 
A.1. Nuclear Magnetic Resonance spectra 
 
 The full spectroscopic characterization of the impz molecule had already been 
reported in a previous dissertation of our research group by M. Sc. Eduardo 
Guimarães Ratier de Arruda. The 1H NMR spectrum of this molecule is given in 
Figure A.1 for informative purposes.  
 
 
Figure A.1. 1H NMR of impz in DMSO – d6. 
 
 Figures A.2 and A.3 shows the 1H and 13C NMR spectra of tzpy in DMSO – 
d6. The 1H spectrum shows four signals, which all integrate to one, corresponding to 
H3 H1 H2 H4 H5/H6 
90 
 
 
 
the four hydrogen atoms of the pyridine ring. The 1H signal attribution (Figure A.2) 
was based on the chemical shifts and coupling constants (given in the main text – 
Experimental Section), which were in agreement with those found for 2-substituted 
pyridine rings.  
 A small and broad signal (not shown) around 3.2 ppm is present on the 
spectrum and it is usually assigned to the hydrogen atom bound to the tetrazole ring. 
As seen from the crystal structure, the hydrogen atom was closer to the pyridine ring. 
However, the hypothesis that this proton can be in equilibrium in solution cannot be 
excluded. Additional experimental evidence for this equilibrium was obtained using 
the {15N, 1H} HMBC NMR technique and the spectrum is given in Figure A.5. 
 
 
Figure A.2. 1H NMR of tzpy in DMSO – d6. 
 
 The 13C spectrum, shown in Figure A.2 shows six signals, which are in 
agreement with the chemical structure of the ligand. Two of them are of lower 
intensity, which is consistent with the presence of two quaternary carbons. 
Assignment of all carbon signals was achieved by {13C, 1H} HSQC and HMBC NMR 
techniques, shown in Figure A.4. The quaternary carbon of pyridine was identified 
due to the 2JC5H4 coupling observed in the {
13C, 1H} HMBC contour map in Figure A.4. 
 
H1 H3 H4 H2 
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Figure A.3. 13C NMR of tzpy in DMSO – d6.  
 
 
Figure A.4. {13C, 1H} (a) HSQC and (b) HMBC NMR contour maps of tzpy. 
  
As seen from Figure A.5, the only nitrogen signal observed showed a 
correlation with H1, which is only possible if it were attributed to the nitrogen atom 
from pyridine, via a 2JH1N1 coupling. No extra signals were observed, even using the 
{15N, 1H} HSQC experiment, which supports the hypothesis of equilibrium involving 
the proton of the tzpy molecule.  
C1 C4 C2 C3 C6 C5 
(a) (b) 
2JC5H4 
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Figure A.5. {15N, 1H} HMBC NMR contour map of tzpy. 
 
 The 1H NMR spectrum of ditzpy (Figure A.6) showed an unexpected broad 
and intense signal of δ at 8.348 ppm. From the chemical structure o ditzpy the pattern 
of signals should be a triplet and a doublet integrating to one and two hydrogens, 
respectively. However, even after purification, the spectrum remained the same. 
Curiously, no other compound involved in the synthesis should give such an intense 
signal (more intense than the solvent signal) or such a pattern. For this reason, 13C 
NMR was not performed. Thus, chemical characterization of this ligand was achieved 
only by mass spectrometry (see Subsection A.2) and elemental analysis. 
 
 
Figure A.6. 1H NMR of ditzpy in DMSO – d6. 
2
J
NpyrH1
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A.2. Mass spectra  
 
 Figures A.7 to A.9 show the mass spectra of the three ligands. In all spectra, 
the [M+H]+ ion can be observed at m/z 147.1, 148.1 and 216.3 for impz, tzpy and 
ditzpy, respectively, which confirms the proposed compositions. Mass spectrometry 
of ditzpy, as opposed to 1H NMR, resulted in the expected composition and no other 
major species indicative of contamination can be observed. 
 
 
Figure A.7. Mass spectrum of impz. 
 
 
Figure A.8. Mass spectrum of tzpy. 
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Figure A.9. Mass spectrum of ditzpy. 
 
impz showed a second peak at m/z 120.1, which corresponds to the loss of 
HCN from the ligand, a common fragmentation of imidazole rings. tzpy showed a 
second peak at m/z 120.0, which can be attributed to the loss of N2 from the ligand. 
ditzpy showed a second peak at m/z 238.0, which is 22 units above the mass of 
[M+H]+, thus indicating the formation of the [M+Na]+ adduct, not observed in the other 
ligands. 
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A.3. Crystal structures – bond lengths and angles  
 
Table A.1. Bond lengths and angles of impz. 
Bond or angle Experimental value (Å or o) 
N(1)-C(1) 1.3707(19) 
N(1)-C(2) 1.3284(19) 
N(2)-C(4) 1.3292(19) 
N(2)-C(5) 1.3362(19) 
N(3)-C(2) 1.3525(18) 
N(3)-C(6) 1.3644(18) 
N(4)-C(3) 1.3428(19) 
N(4)-C(7) 1.3366(19) 
C(1)-C(6) 1.365(2) 
C(2)-C(3) 1.461(2) 
C(3)-C(4) 1.395(2) 
C(5)-C(7) 1.384(2) 
C(1)-N(1)-C(2) 105.27(12) 
C(4)-N(2)-C(5) 116.01(12) 
C(2)-N(3)-C(6) 107.45(11) 
C(3)-N(4)-C(7) 115.84(12) 
N(1)-C(1)-C(6) 110.13(12) 
N(1)-C(2)-N(3) 111.19(12) 
N(1)-C(2)-C(3) 124.74(12) 
N(3)-C(2)-C(3) 123.94(12) 
N(4)-C(3)-C(2) 117.87(12) 
N(4)-C(3)-C(4) 121.41(13) 
C(2)-C(3)-C(4) 120.70(13) 
N(2)-C(4)-C(3) 122.39(13) 
N(2)-C(5)-C(7) 121.99(13) 
N(3)-C(6)-C(1) 105.96(12) 
N(4)-C(7)-C(5) 122.33(13) 
N(3)-C(2)-C(3)-N(4) 5.8(2) 
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Table A.2. Bond lengths and angles of tzpy. The values of only one of the molecules 
necessary to describe the assymetric unit are given.  
Bond or angle Experimental value (Å or o) 
N(1)-C(2) 1.347(2) 
N(1)-C(6) 1.349(2) 
N(2)-N(3) 1.347(2) 
N(2)-C(1) 1.334(3) 
N(3)-N(4) 1.317(2) 
N(4)-N(5) 1.347(2) 
N(5)-C(1) 1.343(2) 
C(1)-C(2) 1.461(3) 
C(2)-C(3) 1.381(3) 
C(3)-C(4) 1.383(3) 
C(4)-C(5) 1.390(3) 
C(5)-C(6) 1.371(3) 
C(2)-N(1)-C(6) 122.26(16) 
N(3)-N(2)-C(1) 104.59(14) 
N(2)-N(3)-N(4) 109.30(15) 
N(3)-N(4)-N(5) 109.96(15) 
N(4)-N(5)-C(1) 103.95(15) 
N(2)-C(1)-N(5) 112.20(16) 
N(2)-C(1)-C(2) 125.53(16) 
N(5)-C(1)-C(2) 122.27(17) 
N(1)-C(2)-C(1) 117.99(17) 
N(1)-C(2)-C(3) 119.07(17) 
C(1)-C(2)-C(3) 122.94(16) 
C(2)-C(3)-C(4) 119.56(17) 
C(3)-C(4)-C(5) 120.21(18) 
C(4)-C(5)-C(6) 118.44(18) 
N(1)-C(6)-C(5) 120.46(17) 
N(2)-C(1)-C(2)-N(1) 1.4(3) 
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Table A.3. Bond lengths and angles of ditzpy.  
Bond or angle Experimental value (Å or o) 
N(1)-N(2) 1.345(4) 
N(1)-N(8) 1.302(4) 
N(2)-C(1) 1.336(5) 
N(3)-C(2) 1.349(4) 
N(3)-C(3) 1.342(5) 
N(4)-N(7) 1.332(4) 
N(4)-C(4) 1.339(5) 
N(5)-N(6) 1.367(4) 
N(5)-C(4) 1.323(5) 
N(6)-N(7) 1.286(5) 
N(8)-N(9) 1.358(5) 
N(9)-C(1) 1.328(4) 
C(1)-C(2) 1.455(5) 
C(2)-C(5) 1.388(5) 
C(3)-C(4) 1.467(4) 
C(3)-C(7) 1.389(5) 
C(5)-C(6) 1.381(6) 
C(6)-C(7) 1.385(4) 
N(2)-N(1)-N(8) 106.2(3) 
N(1)-N(2)-C(1) 109.2(3) 
C(2)-N(3)-C(3) 116.6(3) 
N(7)-N(4)-C(4) 109.4(3) 
N(6)-N(5)-C(4) 105.5(3) 
N(5)-N(6)-N(7) 111.0(3) 
N(4)-N(7)-N(6) 106.4(3) 
N(1)-N(8)-N(9) 110.6(3) 
N(8)-N(9)-C(1) 106.1(3) 
N(2)-C(1)-N(9) 107.9(3) 
N(2)-C(1)-C(2) 124.3(3) 
N(9)-C(1)-C(2) 127.7(3) 
N(3)-C(2)-C(1) 114.9(3) 
N(3)-C(2)-C(5) 123.6(3) 
C(1)-C(2)-C(5) 121.5(3) 
N(3)-C(3)-C(4) 114.4(3) 
N(3)-C(3)-C(7) 124.1(3) 
C(4)-C(3)-C(7) 121.5(3) 
N(4)-C(4)-N(5) 107.8(3) 
N(4)-C(4)-C(3) 124.7(3) 
N(5)-C(4)-C(3) 127.6(3) 
C(2)-C(5)-C(6) 118.1(3) 
C(5)-C(6)-C(7) 119.9(3) 
C(3)-C(7)-C(6) 117.6(3) 
N(2)-C(1)-C(2)-N(3) -1.8(5) 
N(3)-C(3)-C(4)-N(4) -5.2(6) 
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Appendix B 
 
 
Supplements to Chapter 3 
 
 
B.1. 1H NMR spectrum of thim  
 
The spectroscopic characterization of thim can be found in the full paper 
Chapter 3 of this dissertation was based on. The 1H NMR spectrum of this molecule 
is given in Figure B.1 for informative purposes.  
 
 
Figure B.1. 1H NMR of thim in DMSO – d6. 
 
 The assignment of hydrogen atoms was based on coupling constants 
calculations (for the values, see Experimental Section of Chapter 3).  
 
H3 H1 H2 H4 H5/H6 
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B.2. Crystal structure – bond lengths and angles  
 
Table B.1. Bond lengths and angles of [CuCl2(thim)2].  
Bond or angle Experimental value (Å or o) 
Cu(1)-Cl(1) 2.3036(6) 
Cu(1)-N(10) 1.9487(16) 
S(1)-C(5) 1.721(2) 
S(1)-C(2) 1.704(3) 
N(10)-C(10) 1.378(3) 
N(10)-C(6) 1.331(3) 
N(7)-C(8) 1.365(3) 
N(7)-C(6) 1.347(3) 
C(8)-C(9) 1.356(3) 
C(5)-C(6) 1.448(3) 
C(4)-C(5) 1.380(3) 
C(2)-C(3) 1.348(3) 
Cl(1)-Cu(1)-N(10) 88.95(5) 
Cl(1)-Cu(1)-Cl(1)a 180 
Cl(1)-Cu(1)-N(10)a 91.05(5) 
N(10)-Cu(1)-N(10)a 180 
C(2)-S(1)-C(5) 91.86(10) 
Cu(1)-N(10)-C(9) 124.90(13) 
Cu(1)-N(10)-C(6) 128.56(14) 
C(9)-N(10)-C(6) 106.52(16) 
C(8)-N(7)-C(6) 108.70(16) 
N(10)-C(9)-C(8) 109.27(18) 
N(7)-C(8)-C(9) 106.00(18) 
N(10)-C(6)-N(7) 109.50(17) 
N(10)-C(6)-C(5) 126.43(18) 
N(7)-C(6)-C(5) 124.04(17) 
S1-C5-C6-N10 -13.8(2) 
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B.3. FTIR spectra 
 
 
Figure B.2. Full experimental ATR infrared spectra of thim and [CuCl2(thim)2]. 
 
 
 
Figure B.3. Simulated infrared spectra based on DFT calculations with PBE0/def2-
TZVP. Red lines indicate the position of the vibrational transitions.  
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Appendix C 
 
 
Supplements to Chapter 4 
 
 
C.1. 1H NMR spectra 
 
The full spectroscopic characterization of the impy and impm molecules had 
already been reported in a previous dissertation of our research group by M. Sc. 
Eduardo Guimarães Ratier de Arruda. The 1H NMR spectra of these molecule are 
given in Figures C.1 and C.2 for informative purposes. Signal attribution was based 
on coupling constants (given in Experimental Section of Chapter 4).  
 
 
Figure C.1. 1H NMR of impy in DMSO – d6. 
 
H3 H1 H2 H4 H5 H6/H7 
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Figure C.2. 1H NMR of impm in DMSO – d6. 
 
C.2. Mass spectra of the copper(II) complexes 
 
 
Figure C.3. Mass spectrum of [CuCl2(impy)]. 
 
H4 H1/H3 H2 H5/H6 
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Figure C.4. Mass spectrum of [CuCl2(impz)]. 
 
Figure C.5. Mass spectrum of [CuCl2(impm)]. 
 
C.3. Powder diffractograms 
 
 
Figure C.6. X-ray powder diffractograms from the synthesized [CuCl2(impy)] (dotted 
line) and the generated pattern from a reported CIF (full line).  
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Figure C.7. X-ray powder diffractograms from the synthesized [CuCl2(impz)] (dotted 
line) and of the free ligand impz (full line).  
 
C.4. Molecular modeling 
 
 
Figure C.8. Equilibrium geometry and frontier Kohn-Sham orbitals obtained for 
Cuimpy by DFT calculations with PBE0/def2-TZVP. 
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Figure C.9. Equilibrium geometry and frontier Kohn-Sham orbitals obtained for 
Cuimpm by DFT calculations with PBE0/def2-TZVP. 
 
 
C.5. Infrared spectra 
 
 
Figure C.10. Full ATR Infrared spectra of the copper(II) complexes. 
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Figure C.11. Simulated infrared spectra of the copper(II) complexes based on DFT 
calculations with PBE0/def2-TZVP. Red lines indicate the position of the vibrational 
transitions. 
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Appendix D 
 
 
Additional documents 
 
De acordo com a Informação CCPG 001/2015 da Pró-Reitoria de Pós-
Graduação da UNICAMP e a Norma para Encaminhamento de Dissertações e Teses 
da Pós-Graduação/IQ, faz-se necessária a seguinte declaração para a redação da 
Dissertação em formato alternativo ao já estabelecido: 
 
DECLARAÇÃO 
 
As cópias dos documentos de minha autoria ou de minha coautoria, já 
publicados ou submetidos para publicação em revistas científicas ou anais de 
congressos sujeitos a arbitragem, que constam da minha Dissertação de Mestrado 
intitulada “SYNTHESIS, CHARACTERIZATION AND BIOACTIVITY OF COPPER(II) 
COMPLEXES WITH N-HETEROCYCLES/ SÍNTESE, CARACTERIZAÇÃO E 
BIOATIVIDADE DE COMPLEXOS DE COBRE(II) COM N-HETEROCICLOS” não 
infringem os dispositivos da Lei no 9.610/98, nem o direito autoral de qualquer 
editora. 
Campinas, 26 de Fevereiro de 2016. 
 
Autor: Douglas Hideki Nakahata, R.G. no 7.853.732-9 
 
Orientador: Prof. Dr. André Luiz Barboza Formiga, R.G. no 11455693-9 
 
  
108 
 
 
 
D.1. License to reproduce the content of Chapter 3 
 
 
 
109 
 
 
 
 
110 
 
 
 
 
111 
 
 
 
 
112 
 
 
 
 
113 
 
 
 
 
